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ABSTRACT
Studies on the Nucleocapsid Protein of Infectious Bronchitis Virus.
(May 2004)
Jyothi Jayaram, B.S., University of Bombay, India;
M.S., Maharaja Sayajirao University of Baroda, India
Co-Chairs of Advisory Committee: Dr. Ellen W. Collisson
                                                      Dr. Timothy C. Hall
Because phosphorylation of the infectious bronchitis virus (IBV) nucleocapsid
(N) protein may regulate its multiple roles in viral replication, the dynamics of N
phosphorylation were examined. In the infected cell, N was the only viral protein that
was phosphorylated as shown by 32P-orthophosphate labeling and Western blot analysis
and with IBV specific polyclonal chicken antibody. Using pulse-labeling with 32P-
orthophosphate, the IBV N protein was found to be phosphorylated in the virion, as well
as at all times during infection of Vero cells. One-hour pulse-chase analysis followed by
immunoprecipitation of IBV N using rabbit anti-IBV N polyclonal antibody showed that
the phosphate on the protein did not fall below 70% of the maximum and remained
stable. The small but reproducible drop in phosphorylation could modulate the various
functions of the N protein in the infected cell. Simultaneous labeling with 32P-
orthophosphate and 3H-leucine of infected CEK cells indicated a 3.5-fold increase in the
ratio of the 32P:3H counts per minute (cpm) on the virion N protein as compared to the
32P:3H cpm ratio of the N protein from lysates at 7 h p.i. The 32P:3H cpm ratio of the N
iv
protein from virion from infected-Vero cell lysates was 10.5X more than the 32P:3H cpm
ratio of the N protein obtained at 7 h p.i.
It has been shown that the N proteins from the measles and rabies viruses form
helical nucleocapsid-like structures when expressed in bacteria (Schoehn et al., 2001;
Warnes et al., 1995). The ability of E. coli expressed IBV N protein to form helical-
nucleocapsid-like structures was investigated using transmission electron microscopy.
Full-length, purified histidine-tagged IBV N protein formed nucleocapsid-like structures
when expressed in bacteria. Because E. coli -expressed histidine-tagged fragments of the
IBV N protein did not form helical nucleocapsid-like structures, the full-length protein is
probably required for assembly of these structures.
The highly conserved IBV N protein was also used as a diagnostic tool in an
ELISA for detecting anti-IBV antibody in chicken serum using a specialized microwave
called the BIOWAVE. The BIOWAVE improves the processing time for an ELISA.
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1CHAPTER I
INTRODUCTION
INFECTIOUS BRONCHITIS
Coronaviruses are notorious for causing economic losses in agriculture.  Since
first described in 1931, IBV has remained a primary concern for the poultry industry
(Schalk and Hawn, 1931; Cunningham, 1970). Infection caused by IBV is highly
contagious and depending on the strain, it causes respiratory, enteric, kidney, and
reproductive diseases (Albassam et al., 1986; Avellaneda et al., 1994; Chew et al., 1997;
Ziegler et al., 2002). Associated illness is especially severe in young chickens and
persisting virus affects the quality of eggs from adult hens. Live, attenuated vaccines
have been used to control IBV related losses (Ignjatovic and Sapats, 2000). However
because of continuing genetic variations, field outbreaks continue to occur that
antigenically differ from the vaccine strains (Collisson et al., 1992; Ignjatovic and
Sapats, 2000). It is necessary to develop new methods to control IBV. A thorough
understanding of the molecular biology of the virus can lead to the development of more
effective control measures.
Classification
Infectious bronchitis virus (IBV) belongs to the Nidovirales order and family
Coronaviridae. The primary features which define membership of the Nidovirales are:
The format of this dissertation follows that of the journal Virology.
21) Linear, non-segmented, positive-sense, single stranded RNA genomes. 2) Genome
organization: 5’-replicase gene-structural proteins genes-3’. 3) A 3’ co-terminal nested
set of four or more subgenomic RNAs. 4) The genomic RNA functions as the mRNA for
the translation of the replicase polyprotein. 5) The 5’ unique regions of the mRNAs, i.e.
those absent from the next smaller RNA are translated (Cavanagh, 1997). Comparative
sequence analysis of the non-structural and structural proteins of the viruses have led to
their classification under the Arteriviridae, Coronaviridae and Roniviridae families
(Gonzalez et al., 2003). The classification of the family Coronaviridae into the
Coronavirus and the Torovirus genera is based on similarities in genome organization
and the expression of their genomes and the structures of the viral gene products (Siddell
et al., 1995). The genome size ranges from 13 to 15 kilobases for arteriviruses and from
27 to 32 kilobases for coronaviruses. Coronaviruses, like the toroviruses and the
arteriviruses, have a unique, discontinuous transcription strategy that produces several
subgenomic mRNAs and the genomic RNA. The subgenomic mRNAs form 3’ co-
terminal nested sets in which each mRNA contains the common 3’ untranslated region
and 5’ leader sequence (Siddell et al., 1995).
Viruses belonging to the genus coronavirus cause respiratory, gastrointestinal,
cardiovascular, and neurological disease in domestic animals, including poultry, and in
humans (McIntosh et al., 1974). Based on antigenic cross-reactivity and sequence
analysis of structural protein genes, coronaviruses are classified into three distinct
groups. Group I includes human coronavirus 229E (HCoV-229E), transmissible
gastroenteritis virus (TGEV), canine coronavirus (CCV), feline coronavirus (FECV),
3and feline infectious peritonitis virus (FIPV). Group II includes human coronavirus
OC43 (HCoV-OC43), murine hepatitis virus (MHV), porcine hemagglutinating
encephalomyelitis virus (HEV), sialodacryoadenitis virus (SDAV), and bovine
coronavirus (BCoV). Group III includes IBV, a type of turkey coronavirus (TCV) and
pheasant coronavirus (Siddell et al., 1995). Recently, a new, genetically unique, human
coronavirus was isolated as an etiological agent of severe acute respiratory syndrome
(SARS). Although coroanviruses are host-specific, the SARS coronavirus (SCoV) was
also isolated from a civet and the closely related raccoon dog (Drosten et al., 2003;
Ksiazek et al., 2003; Peiris et al., 2003). The genome organization of the SCoV is
typical of coronaviruses. Like the group III coronaviruses, the SCoV has several small
non-structural open reading frames (ORFs) that are found between the S and E genes
and between the M and N genes (Rota et al., 2003). Phylogenetic analysis of different
SCoV proteins using unrooted trees showed that SCoV does not segregate into any of
the three currently established coronavirus groups (Marra et al., 2003; Rota et al., 2003).
However, when ORF1b of the equine torovirus (EToV) was included in the analysis, the
SCoV was distantly related to the group II coronaviruses (Snijder et al., 2003).
 Morphology
The name coronavirus refers to the corona-like appearance formed by the spike-
like projections of the spike (S) glycoprotein on the surface of the virus (Davies and
Macnaughton, 1979). These prominent surface projections of up to 20 nm in length
cover the entire virion surface. However, TCV, has smaller spikes on the virion surface
(Dea and Tijssen, 1988). Coronavirus virions are pleiomorphic, ranging from 80-160 nm
4in diameter and are composed of four major structural proteins, the nucleocapsid (N)
protein, the matrix (M) protein, the spike (S) protein and small envelope (E) protein. The
N protein directly binds viral genomic RNA and forms a helical ribonucleoprotein
complex (RNP) with a morphology similar to paramyxovirus (Davies et al., 1981). In
the case of TGEV, electron microscopic data suggest a possible icosahedral core shell
structure comprising of the N, M and E proteins (Risco et al., 1996). Certain strains of
BCoV and MHV also have a hemagglutinin-esterase (HE) protein.
Genome organization
 The genomes of the coronaviruses ranging from about 27.6 to 32 kilobases (kb)
are the largest genomes of all the known RNA viruses. IBV and other coronaviruses
have a positive stranded RNA genome that is transcribed into full-length negative
stranded RNA after infection (Lai et al., 1982). The purified genomic RNA is infectious
and therefore can also function as an mRNA. The genomic RNA encodes the viral RNA-
dependent RNA polymerase (Lomniczi, 1977; Schochetman et al., 1977). In infected
cells, depending on the virus, coronaviruses produce from five to seven subgenomic
RNAs in addition to the genomic RNA (Lai et al., 1982; Siddell, 1983; Stern and
Kennedy, 1980a; Stern and Kennedy, 1980b). All RNAs are 3’ polyadenylated and
numbered according to their size. IBV has five subgenomic RNAs and the genomic
RNA. They are numbered 1 through 6 based on size with the genome as RNA 1 (Fig.
1.1). The polyadenylated mRNAs form a 3’ co-terminal nested set that extend for
different lengths in the 5’ direction (Leibowitz and Weiss, 1981; Stern and Kennedy,
1980a; Stern and Kennedy, 1980b). Genomic and subgenomic RNAs have 3’ and 5’
5FIG. 1.1. IBV genomic and subgenomic RNA. RNAs 1-6 form a 3’co-terminal nested
set. RNA 1 encodes proteins of the replicase complex, 2 encodes the spike protein, 3
encodes the 3a, 3b and E proteins, 4 encodes the M protein, 5 encodes the 5a and 5b
proteins and 6 encodes the nucleocapsid protein.
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6untranslated (UTR) regions. These sequences are believed to function as cis-signal
sequences for viral replication and transcription. For the various coronaviruses, the 5’
end of each mRNA has about 60 to 72 nucleotides common to every RNA called the
leader sequence (Lai et al., 1983; Lai et al., 1982; Spaan et al., 1982). In the subgenomic
RNA, following the leader sequence, most coronavirus ORFs are preceded by an
untranslated region of various lengths that contain a conserved intergenic (IG) or
transcription associated sequence (TAS).
The genome organization of IBV is similar to that of other prototype
coronaviruses, such as MHV and TGEV, in having the “replicase gene-S-E-M-N” gene
order together with small “nonstructural” proteins, such as 3a, b and 5a, b of IBV
(thought to be group specific antigens), interspersed between the larger ORFs (Fig. 1.2).
Due to its smaller genome size (27 kb) as compared to other coronaviruses (31 kb of
MHV), the IBV genome is more efficient and compact. Some of the ORFs overlap with
the previous or following ORF, for example, the 3’ terminal end of 1b overlaps with the
5’ end of the S ORF by about 50 nucleotides (Casais et al., 2003).
IBV proteins
Polymerase: Approximately 70% of the coding potential of the IBV genome
encodes the viral polymerase. Nucleotide sequencing has shown that mRNA 1 contains
two large overlapping ORFs (1a and 1b), with ORF 1a having the potential to encode a
polyprotein of 441 kilodaltons   (kDa) (named polyprotein 1a) (Boursnell et al., 1987).
Translation of ORF 1b requires a ribosomal frame-shifting event at the 3’-end of ORF
1a, resulting in the synthesis of polyprotein 1ab (741 kDa) (Brierley et al., 1987;
7FIG. 1.2. Open reading frames of IBV. Genomic RNA (1) and ORFs (2-6) are
represented by blue lines. Colored bars denote positions, relative to the RNAs and to
each other, for the encoded polypeptides: 1a, 1b (replicase complex); S (spike
glycoprotein); 3a, 3b, E (envelope); M (membrane glycoprotein); 5a, 5b and N
(nucleocapsid protein). Functional domains indicated within the polypeptides 1a and 1b
are: PLP (papain-like protease); 3CLP (3C-like protease); CR (cysteine-rich region);
RdRP (RNA-dependent RNA polymerase; MB (metal binding domain) and RH (RNA
helicase). Mature and putative (?) products of ORF 1a and ORF 1b are indicated in black
with the numbers representing the approximate molecular mass in kilodaltons.
8Brierley et al., 1989). This mechanism has proven to be universal in the expression of
ORF 1b in all coronaviruses studied so far (Liu et al., 1994). Polyprotein 1ab is post-
translationally cleaved by a virus-encoded papain-like proteinase (PLP) and a 3C-like
proteinase (3CLP) to form 9 and 15 products in IBV (Fig. 1.2) and MHV respectively
(Lim et al., 2000; Liu et al., 1997; Sims et al., 2000). PLP is an accessory proteinase that
cleaves polyprotein 1a and 3CLP is the main proteinase that cleaves polyprotein 1ab to
give the mature polypeptides (Lim et al., 2000; Liu et al., 1994; Liu et al., 1998; Liu et
al., 1997). Both proteinases are encoded by ORF 1a. Sequence analysis has identified
four putative functional domains in ORF 1b, namely the RNA-dependent RNA
polymerase (RdRP), the metal binding region (MB), the RNA helicase (RH) (Liu et al.,
1997) (Fig. 1.2) and a Cap-1 methyltransferase region found in the SCoV (von Grotthuss
et al., 2003). With the exception of the experimentally confirmed viral proteinases and
the predicted polymerase proteins, the functions of the remaining mature gene 1 proteins
have not been determined (Sims et al., 2000). Sequence analysis has shown the presence
of two PLP domains in MHV and HCoV, however only one such domain is present in
IBV and SCoV (Snijder et al., 2003; Ziebuhr et al., 2000). Two RNA polymerase
activities, one early and the other late in infection have been detected in MHV-infected
cells. The early polymerase, but not the late polymerase, could be activated by potassium
ions in the absence of magnesium ions and it also had a lower optimum pH than the late
polymerase (Brayton et al., 1982). Viral RNA in MHV-infected cells was detected in
dense membrane fractions containing helicase, p28, and N but not in less dense
membrane fractions containing p65 and p1a-22.   p28 and p65 are 28- and 65- kDa
9amino-terminal cleavage products of ORF1a respectively, and p1a-22 is a 22-kDa-
cleavage product of ORF1a at the C-terminal end. This demonstrates that the multiple
gene 1 proteins segregate into two biochemically distinct but tightly associated
membrane populations and only one of these sites appears to be the site for viral RNA
synthesis (Sims et al., 2000; Xu et al., 2001).
Spike (S) glycoprotein: The spike protein, a type I glycoprotein is a determinant
of cell tropism (Casais et al., 2003; Popova and Zhang, 2002). By replacing the
ectodomain of the spike gene of FIPV with that of MHV by targeted recombination, the
species tropism of FIPV can be altered such that it now infects murine cells instead of
feline cells (Haijema et al., 2003). Similar to most coronaviruses, the IBV S glycoprotein
(1,162 amino acids) is post-translationally cleaved into two subunits, S1 (535 amino
acids; 90 kDa), comprising the N-terminal half of the S protein, and S2 (627 amino
acids; 84 kDa), comprising the C-terminal half of the S protein. The S1 subunit contains
the receptor-binding activity of the S protein (Casais et al., 2003). The S2 subunit
associates noncovalently with the S1 subunit and contains the transmembrane and C-
terminal cytoplasmic domains. The ectodomain of the S2 subunit contains a fusion
peptide-like region (Luo and Weiss, 1998) and two heptad repeats involved in
oligomerization of the S protein (de Groot et al., 1987). Binding of the MHV JHM strain
S protein to soluble MHV receptor induces a conformational change in the membrane-
anchored fragment of the S protein (Matsuyama and Taguchi, 2002). This activity is
probably important in virus entry into the host cell.  The S proteins of most
coronaviruses are immunogenic and are immune targets for viral inhibition.
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Membrane (M) protein: The membrane (M) protein, a type III integral
membrane protein, is the most abundant glycoprotein in the viral envelope. It consists of
a short amino-terminal ectodomain, three successive transmembrane domains, and a
long carboxy-terminal domain on the inside of the virion (Fig. 1.3) (Siddell et al.; 1995).
The 225-amino acid IBV M protein has a predicted molecular weight of approximately
25 kDa. However, the molecular weight in infected cells is approximately 30 kDa
(Siddell et al.; 1995). Depending on the coronavirus, the M protein may have O or N
linked glycosylation. MHV M protein has O-linked glycosylation and targets to the
trans-Golgi apparatus (Locker et al., 1995; Niemann and Klenk, 1981; Sturman and
Holmes, 1977). However, IBV M has N-linked glycosylation (Cavanagh, 1983; Locker
et al., 1992) and targets to the cis-Golgi (Machamer et al., 1990).
Small envelope (E) protein: The E protein is a minor but essential component of
the virion. It was only recently recognized as a structural protein. The IBV E protein is
composed of 108 amino acids with a predicted molecular mass of approximately 10 kDa.
In contrast to other viral structural proteins, the coronavirus E protein is expressed by a
cap-independent translation mechanism that uses the internal ribosome entry site (IRES)
located between ORFs 3a and 3b in the IBV genome and in the 5a region in the MHV
genome (Liu and Inglis, 1992; Thiel and Siddell, 1994). The E protein is present in
minute amounts in the virus envelope (Liu and Inglis, 1991; Raamsman et al., 2000).
The putative peripheral domain of the E protein interacts with the M protein
thereby retaining the M protein in the pre-golgi compartment where the virus buds
11
FIG. 1.3. IBV membrane (M) protein. It is a triple membrane spanning protein with the
N-terminal end on the outside of the virion and the long C-terminal end in the inside of
the virion. The potential N-linked glycosylation site is marked by a hexagon. (Adapted
from Siddell et al., 1995)
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(Lim et al., 2001). Corse and Machamer (2000) have shown that the E protein localizes
to the golgi and then interacts with the M protein via the C-terminal tail (Corse and
Machamer, 2000; Corse and Machamer, 2002; Corse and Machamer, 2003). The E and
M proteins alone can form virus-like particles (i.e. particles that lack any nucleocapsid
though resemble the virus in shape and size) when co-expressed in Vero cells (Baudoux
et al., 1998; Corse and Machamer, 2000). The E:M stoichiometry in the VLPs have not
been determined. Besides the cytoplasmic tail of the E protein, the transmembrane
domain may also be important in interacting with the M protein in virus assembly (Corse
and Machamer, 2003). The S protein co-localizes with the M protein in the Golgi and is
incorporated into virus-like particles when co-expressed with the M and E proteins. S is
however dispensable for formation of virus-like particles (Corse and Machamer, 2000;
de Haan et al., 1998; Nguyen and Hogue, 1997; Vennema et al., 1996). Since E is
present in the particles in very small amounts, interactions between M proteins
apparently generate the major driving force for envelope formation. The M protein
molecules interact with each other through multiple contact sites, particularly within the
lipid envelope (de Haan et al., 2000).
Hemagglutinin esterase (HE) protein: HE, an N-linked glycoprotein is present
only in BCoV, TCV, HCoV, and some strains of MHV but is absent in IBV, SCoV and
TGEV. This glycoprotein shares some sequence homology with the hemagglutinin
protein of influenza C virus and the gene is proposed to be derived from influenza virus
by non-homologous recombination. The HE protein of BCoV and some strains of MHV
exhibit hemagglutination and esterase activity. Monoclonal antibodies specific for the
13
HE protein of BCoV can inhibit virus-induced hemagglutination and neutralize viral
infectivity implying that at least in BCoV, HE plays a role with S in viral attachment
(Snijder et al., 2003).
Nucleocapsid (N) protein: The nucleocapsid (N) protein is the only protein
known to be phosphorylated in MHV, TGEV, IBV and HCoV (Siddell, 1995). IBV N
protein is 409 amino acids long (approximately 48 kDa). It is a basic protein rich in
lysine (39 residues) and arginine (34 residues) amino acids, with a predicted isoelectric
point of 9.69. The IBV N protein has thirty-three serine, eighteen threonine, and eight
tyrosine residues, any of which could be potential sites for phosphorylation (Table 1.1).
MHV N is found in the cytosol of infected cells as well as being associated with cellular
membranes. IBV N protein localizes to the nucleolus in the absence of other viral
proteins as well as in the virus-infected cell. TGEV and MHV N also localize to the
nucleolus in the absence of other viral proteins, though not in the virus-infected cell as
90 % of the infected cells do not have detectable N in the nucleolus (Hiscox et al., 2001;
Wurm et al., 2001). IBV N protein has many arginine and lysine residues but lacks any
domain characteristic of known RNA binding proteins (Williams, 1993). The N protein
is multifunctional. It has been implicated in playing a role in genome replication,
transcription of subgenomic RNA, translation and in formation of the nucleocapsid
(Masters et al., 1990; Masters and Sturman, 1990; Tahara et al., 1998). It interacts with
the cellular heterogenous ribonuclear protein A1 in vivo and in vitro (Wang and Zhang,
1999). It has been proposed that phosphorylation might regulate the multifunctionality of
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Table 1.1.
Physicochemical properties of the IBV N protein
Characterisitc
Molecular weight ~ 48 kDa
Predicted isoelectric point 9.69
Actual isoelectric point unknown
Number of serine residues 33
Number of threonine residues 18
Number of tyrosine residues 8
Number of lysine residues 39
Number of arginine residues 34
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the protein (Masters and Sturman, 1990). In MHV, a protein kinase activity was found
associated with purified virus preparations of MHV indicating the presence of a kinase
in the virion (Siddell et al., 1981).
IBV life cycle
Coronaviruses are host-specific. The virion binds to the cell membrane receptors
by either the S glycoprotein, or by sequential binding of HE followed by binding of S.
Conformational changes either in the S protein or the receptor or both, may be induced
by virus binding and lead to fusion of the viral envelope with host cell membranes.
MHV-A59-induced fusion is optimal at neutral or mildly alkaline pH. For HCoV-229E,
IBV and some MHV variants, fusion does not occur at neutral pH and the virus
envelope may fuse with the endosomal membrane rather than the plasma membrane
(Gallagher, 1997; Sturman et al., 1990). In some of the coronaviruses, binding of the
spike protein to the receptor causes the cleavage or maturation of the spike protein
(Siddell, 1995). The receptor for some of the coronaviruses has been identified. The
MHV receptor (MHVR) belongs to the carcinoembryonic antigen (CEA) related
glycoprotein in the biliary glycoprotein subgroup (Dveksler et al., 1993; Dveksler et al.,
1991).  Both TGEV and HCV-229E utilize amino peptidase (APN) glycoproteins as
receptors (Siddell, 1995). SCoV uses angiotensin-converting enzyme 2, a
metallopeptidase, as the receptor (Li et al., 2003).
Coronaviruses replicate in the cytoplasm. Following uncoating to release the
nucleocapsid, coronaviruses express the largest known replicase polyproteins (741 kDa),
which in turn are proteolytically processed to yield a large number of mature proteins,
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including the RNA-dependent RNA polymerase (Fig. 1.2). During infection, virion RNA
is initially copied by an early (detected 1 hour post-infection) polymerase activity into a
genome-sized negative stranded RNA (Brayton et al., 1982). The negative stranded
RNA is transcribed by a late (detected 6 hours post-infection) polymerase activity into a
full-length genomic RNA that is bound to polysomes and detected in EDTA resistant
forms. Maximum virus production occurs at approximately 13 hours post-infection
(Brayton  et al., 1982). Fractionation of the membranes by sucrose gradient
sedimentation showed that the early polymerase activity was homogeneous, while the
late polymerase was associated with two distinct membrane fractions. The light peak of
the late polymerase synthesized genomic-sized RNA of positive sense, while the heavy
peak of the activity synthesized positive-sensed genomic and subgenomic mRNAs.
These findings suggest that the light peak of the late polymerase represents a replication
complex while the heavy peak represents a transcription complex (Brayton et al., 1984).
Processes that lead to the formation of the mature virus are membrane associated.
Besides the polymerase, other viral proteins are synthesized from the subgenomic RNA.
The subgenomic RNAs are created by some type of discontinuous synthesis, rather than
by splicing of a genomic precursor (Siddell, 1995). At least one stage of their synthesis
requires base-pairing interactions between the positive strand of the leader and the
negative strand of the intergenic sequence (IGS) or transcription associated sequence
(TAS). The exact nature of the discontinuous leader-body fusion step, whether it occurs
during positive strand or negative strand synthesis, and the significance of the negative-
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strand counterparts of the subgenomic RNAs are all matters of controversy (Jeong and
Makino, 1992; Sawicki and Sawicki, 1990; Sethna et al., 1989).
The discovery of subgenomic negative strands has led to two different models for
coronavirus transcription based on the nature of the template(s) for mRNA synthesis.
The first model is a leader-primed transcription model (Fig. 1.4A). According to this
model, discontinuous transcription occurs during positive stranded RNA synthesis.
Leader RNAs are transcribed from one end of the negative stranded RNA template. The
leader RNA then dissociates from the template, and subsequently binds to any IGS or
TAS on the negative stranded template. This serves as the primer for subgenomic RNA
transcription, resulting in subgenomic positive strand RNA synthesis that contains a
leader RNA fused to the body RNA. This model is based on the presence of genome-
length replicative intermediates (RIs) (the double-stranded structure that "produces"
RNA is designated the RI) in MHV-infected cells and of free leader RNAs in infected
cells (Baric et al., 1983; Baric et al., 1985). Visualization of double-stranded RNAs by
gel electrophoresis and fluorography usually involves digestion of the excess single-
stranded RNA by RNase A. The remaining double-stranded RNase-resistant molecules
are referred to as the replicative forms (RFs). The RFs do not always correspond to the
RIs because the RIs could have been digested at certain RNase-sensitive sites to yield
smaller RFs. Several small leader sequence-related RNA species have been detected in
the cytoplasm of MHV-infected cells (Baric et al., 1985) These leader RNAs are distinct
in size and reproducible in different cell types. However, most of these leader RNAs are
either larger or smaller than the leader sequence present at the 5’ end of the mRNAs
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FIG. 1.4. Schematic representation of two transcription models. Plus- and minus-
strands are represented by black and gray arrows respectively. On the plus-strand, the
leader sequence and intergenic region are indicated in red; on the minus-strand, the
intergenic sequence is shown in black. The two models differ in that the template for the
subgenomic mRNAs is different. (A) A genomic minus-strand is the template for
subgenomic mRNA synthesis. The subgenomic mRNAs are first synthesized by leader-
primed transcription and are then amplified. (B) Subgenomic minus-strands are
synthesized by premature termination of transcription and serve as templates for leader-
primed transcription.
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implying that additional processing of these leader RNAs may occur during mRNA
transcription. Temperature-sensitive (ts) mutants have been isolated that synthesize only
the small leader-related RNAs but not mRNAs at the non-permissive temperature (Baric
et al., 1985). Thus it is possible that the synthesis of the leader RNA and mRNAs are
two separate and discontinuous events. In vivo and in vitro studies support this model.
When cells with different strains of MHV were co-infected or exogenous leader RNA
was introduced into virus infected cells, leader sequence from different strains of MHV
or the exogenous leader RNA was incorporated in trans into subgenomic mRNAs at
precisely the leader-mRNA junction sites (Baker and Lai, 1990). This process is called
leader switching and is also observed in IBV (Stirrups et al., 2000).
The second model is a discontinuous transcription model. A discontinuous
transcription step potentially occurs during negative strand RNA synthesis (Fig. 1.4B).
During negative strand RNA synthesis from the full-length genomic RNA template, the
RNA dependent RNA polymerase (RdRp) pauses at one of the IG or TAS sequences and
then jumps to the 3’ end of the leader sequence at the 5’ end of the genomic RNA
template, generating a subgenomic negative stranded RNA with an antisense leader
sequence at its’ 3’ end. This subgenomic negative stranded RNA then serves as a
template for synthesis of mRNAs. Several studies have shown that both genomic and
subgenomic sized negative stranded RNAs are present even though positive stranded
RNA are present at higher levels (Baric and Yount, 2000; Sawicki and Sawicki, 1990;
Schaad and Baric, 1994; Sethna et al., 1991). Schaad and Baric (1994) have shown that,
at least late in infection, the subgenomic negative-strand RNAs were the functional
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templates for subgenomic mRNA synthesis. All the negative stranded RNAs were in
double-stranded form and no free negative stranded RNA was detected.
Defective interfering (DI) particles of viruses typically accumulate in stocks of
virus that are passaged serially at high multiplicity or they can be assembled by genetic
manipulation of the parent virus. The following are the defects of DI particles: (a) they
have defects (either point mutations or deletions) in essential genes, (b) they interfere
with the growth of the parent or helper virus and (c) they enrich themselves at the
expense of the parents or helper virus (Lai and Holmes, 2001). Since infectious cDNA
clones of coronaviruses have only recently become available, either naturally occurring
or artificially constructed DI RNA of bovine coronavirus and mouse hepatitis virus have
been used to identify five putative UTR-localized, cis-acting replication elements. Four
of these elements within the 3’-UTR are phylogenetically conserved in various
coronaviruses. They include the 3’-terminal poly (A) tail (Spagnolo and Hogue, 2000), a
long range stem interaction between nt 65 to 71 and 124 to 130 from the base of the poly
(A) tail in BCoV (nt 68 through 74 and 136 through 142 in MHV-JHM) (Liu et al.,
2001), a hairpin-type pseudoknot consisting of nt 173 through 226 in BCoV (nt 185
through 238 in MHV A59) (Williams et al., 1999), and a 5’- proximal extended bulged
stem-loop consisting of nt 222 through 289 in BCoV (nt 234 through 301 in MHV-A59)
mapping immediately downstream of the N gene stop codon and overlapping the
pseudoknot by 5 nt (Hsue et al., 2000; Hsue and Masters, 1997). A 65 nt leader,
comprising an identified stem-loop I and part of an identified stem-loop II has been
shown to function in BCoV DI replication (Chang et al., 1994). Stem loop III in the 5’
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UTR of BCoV has been shown to function as a cis-acting element for DI RNA
replication. An ORF associated with this stem-loop region may function to enhance
replication. It is postulated that these two elements function similarly in the virus
genome (Raman et al., 2003). There is evidence to suggest that coronavirus transcription
involves interaction between leader mRNA and the intergenic (IG) sequences, probably
via RNA-protein interactions (Zhang and Lai, 1994). The 5'-terminal 544 nucleotides
(nt) and 3'-terminal 338 nt contain the necessary signals for IBV DI RNA replication.
Phylogenetic analysis of 19 strains of IBV and 3 strains of turkey coronavirus predicted
a conserved stem-loop structure at the 5' end of region II of the 3' UTR. Removal of the
predicted stem-loop structure abolished replication of the DI-RNAs (Dalton et al., 2001).
Various cellular proteins are known to bind to the coronavirus cis-acting RNA
regulatory elements (Furuya and Lai, 1993). These include polypyrimidine-tract-binding
protein (PTB) (Li et al., 1999), heterogenous ribonucleoprotein (hnRNP) A1 (Li et al.,
1997), mitochondrial aconitase (Nanda and Leibowitz, 2001), poly (A)-binding protein
(PABP) (Spagnolo and Hogue, 2000), and several other unidentified proteins. HnRNP-
A1 binds in vitro to probe RNAs containing negative-sense strand of MHV IGS (Li et
al., 1997; Zhang and Lai, 1995). Although coronavirus RNA has not been shown to
enter the nucleolus, the N-protein of MHV has been shown to interact with cellular
hnRNP A1, a protein that has been shown to participate in alternative splicing in the
nucleus, mRNA export from the nucleus to the cytoplasm, and telomere biogenesis and
maintenance. hnRNP A1-N protein interaction has been shown in vitro and in vivo using
the yeast two-hybrid system and by immunoprecipitation from MHV-infected cells. The
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interaction between these proteins may be important in regulating RNA transcription
(Wang and Zhang, 1999). hnRNP A1 and PTB bind to complementary sequences at the
5’ end of MHV RNA and together mediate the formation of an RNP complex involving
the 5’- and 3’-end fragments of MHV RNA in vitro. DI RNAs containing a mutated
hnRNAP A1-binding site have lower RNA transcription and replication activities. These
results and the finding that hnRNP A1 binds to the 3’-UTR is compatible with the
interpretation of the authors that hnRNP A1 mediates potential 5’-3’-end cross talk of
MHV RNA (Huang and Lai, 2001). Contradictory evidence exists to show that this
protein regulates MHV RNA synthesis (Shi et al., 2000), and also that it is not necessary
for MHV replication. The absence of hnRNP-A1 has no detectable quantitative or
qualitative effect on MHV RNA synthesis (Shen and Masters, 2001). Work done by
Nanda et al. (2001) suggests that binding of mitochondrial aconitase to the MHV 3’-
UTR substantially increases the production of infectious virus and the expression of
MHV proteins during the early stages of infection (Nanda and Leibowitz, 2001).
A packaging signal sequence within ORF 1b for MHV and BCoV and within the
5’ 649 nucleotides of the genome for TGEV confers packaging ability to non-viral RNA
(Cologna and Hogue, 2000; Escors et al., 2003; Fosmire et al., 1992). The IBV
packaging signal sequence has not yet been identified although a similar sequence can be
found in its 1b ORF as in MHV and BCoV. RNA-independent interaction between
MHV M and N proteins occurs in MHV infected cells (Narayanan et al., 2000). Co-
expression of MHV M and E proteins and RNA containing the MHV packaging signal
sequence results in the production of VLPs containing the RNA transcripts; the N and S
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proteins are indispensable for this process (Narayanan et al., 2003a; Narayanan and
Makino, 2001). Nucleocapsid independent-assembly of VLPs is possible by co-
expressing the M and E proteins from transfected plasmids. A combination of M-M, M-
N, M-RNA, N-RNA interactions are all likely to be important in specifically packaging
the viral genome (Vennema et al., 1996).
A critical part of viral morphogenesis is the assembly of the helical nucleocapsid,
made up of the viral RNA and the N protein (Spaan et al., 1981; Stohlman et al., 1983).
The order of events leading to virion formation is not known. It is not known if the
nucleocapsid is preformed in the cytoplasm and rapidly transported to the membranes
where assembly occurs or whether it is assembled in association with cellular
membranes. The nucleocapsid associates with smooth membranes belonging to the
endoplasmic reticulum-Golgi intermediate compartment (ERGIC) that constitutes the
“budding compartment” for coronaviruses (Krijnse-Locker et al., 1994). Two types of
virus-related particles are found during coronavirus morphogenesis. The virus that is
assembled and found near the perinuclear region is larger than the virus that is finally
released from the cell. The virus that is released from the cell is formed as a result of
maturation by passing through the Golgi and emerging from the trans-Golgi network
(Risco et al., 1998; Salanueva et al., 1999).
RNA-PROTEIN INTERACTIONS
Introduction
Specific interactions between RNA and proteins are fundamental to many
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cellular processes including the assembly and function of ribonucleoprotein particles
(RNPs), such as ribosomes and spliceosomes and the post-transcriptional regulation of
gene expression (Draper, 1995). These interactions are also important in DNA and RNA
viruses. Motifs characteristic of RNA and DNA binding proteins have been identified in
several proteins. Multiple copies of ribonucleoprotein (RNP) motifs have been identified
in heterogenous nuclear RNP (hnRNP) and in yeast poly (A) binding protein (Sachs et
al., 1986; Adams et al., 1996). Although these domains may bind RNA/DNA non-
specifically, they typically bind their natural sequences with greater affinity. An
arginine-rich motif present in the carboxyl terminus of the HIV tat protein binds to a
small hairpin of the HIV TAR RNA (Calnan et al., 1991). Closely spaced Arg-Gly-Gly
(RGG) box and KH motifs have been found to interact with RNA sequences (Burd and
Dreyfuss, 1994). Zinc-finger motifs have been identified in a number of proteins as
associated with nucleic acid interactions (Draper, 1995). Zinc-fingers of TFIIA, which
are repeats of CX4CX12HX3-4H, interact with 5S RNA and the same sequences in
duplex DNA (McCall et al., 1986). The RNA recognition motif 2 (RRM 2) of guanine-
rich sequence factor-1 (GRSF-1) is required for regulating translation of viral RNA.
Cellular and viral mRNAs containing 5' UTR GRSF-1 binding sites are recruited by
GRSF-1 to polyribosomes. This recruitment is mediated through interactions with
cellular proteins (Kash et al., 2002). The KH domains of Xenopus Vg1 RNA binding
protein (Vg1RBP) mediate RNA binding and self-association (Git and Standart, 2002).
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RNA motifs
Several RNA motifs, important in RNA folding, in RNA-RNA interactions and
in RNA-protein interactions have been identified: terminal loop motifs, internal loop
motifs, and tertiary motifs. U-turns and tetraloops are terminal loop motifs of stem loops;
Internal loops may be classified as cross-strand purine stacks, bulged-G motifs, A-
platforms, bulge-helix-bulge motif and/or metal binding motifs; RNA tertiary structural
motifs include the ribose zipper and the tetraloop-helix interactions. The coaxial stack
and the pseudoknot also contribute to RNA tertiary structure (Moore, 1999). The most
frequently occurring and better-studied tetraloop sequences are the cUNCGg, the
cGNRAg, and the gCUUGc sequences. The uCACGg tetraloop occurs naturally within
the cloverleaf RNA structure of the 5'-UTR of coxsackievirus B3. The cloverleaf
structure is the main determinant for interaction with the viral 3C protease, which is a
component of the RNP complex that is involved in regulating viral RNA replication and
translation (Du et al., 2003). The central domain of the foot-and-mouth disease (FMDV)
IRES contains a conserved GNRA motif, essential for IRES activity. Mutants bearing
the UNCG or GUAG tetraloops instead of the GNRA tetraloop revealed lack of
protection to chemical attack in native RNA at specific nucleotides relative to the
parental GUAA, suggesting that the GNRA motif dictates the organization and stability
of the central domain of the IRES. This suggests that the GNRA motif plays a crucial
role in the organization of IRES structure with important consequences on activity
(Fernandez-Miragall and Martinez-Salas, 2003). The CUUG tetraloop is commonly
found in bacterial 16S rRNA (Baumruk et al., 2001). Bacterial ribosomal protein L5
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specifically interacts with the bulged nucleotides at the top of loop C of 5S rRNA. The
rRNA and protein contact surfaces are strongly stabilized by intramolecular interactions.
Charged and polar atoms forming the network of conserved intermolecular hydrogen
bonds are located in two narrow planar parallel layers belonging to the protein and
rRNA, respectively. The regions, including these atoms in the RNA and the protein,
conserved in bacteria and archaea, can be considered an RNA-protein recognition
module (Perederina et al., 2002). The internal loop/bulge and hairpin loop of the iron-
responsive element of ferritin mRNA, contribute to maximal iron regulatory protein 2
binding and translational regulation in the iso-iron-responsive element/iso-iron
regulatory protein family (Ke et al., 2000). RNA elements that bind cellular proteins
have been used as a decoy to regulate mRNA transcription and translation (Coulis et al.,
2000; Garcia-Gras et al., 2000). The 5’ UTR of turnip yellow mosaic virus  (TYMV)
contains two conserved hairpins with internal loops consisting of C-C and C-A
mismatches. Packaging occurs at a pH below N1 pKa of cytosine, and the hydrogen
bond arising there from permits a C-C or C-A mismatch, the presence of the latter being
proven by mutagenesis. It has been suggested that this RNA-protein interaction is a new
type of interaction that is accompanied by base pairing of protonatable bases under
acidic conditions (Bink et al., 2002). Both sequence specific and nonspecific interactions
between the Escherichia coli DEAD protein DbpA and the small RNA hairpin in 23S
rRNA are required for activation of the ATPase activity of the DEAD protein (Tsu et al.,
2001). Translation initiation factors such as eIF3, eIF4B, and eIF4G bind to the internal
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ribosome entry site (IRES) of certain viruses and some of these interactions affect
translation efficiencies (Lopez de Quinto et al., 2001).
Purine-rich sequences
Certain purine-rich regions are important in RNA-protein interactions.
Replication of human immunodeficiency virus requires Tat protein which activates
elongation of RNA polymerase II transcription at the HIV-1 promoter through
interaction with the cyclin T1 (CycT1) subunit of the positive transcription elongation
factor complex (P-TEF) and the TAR RNA element. CycT1 does not bind TAR RNA in
the absence of Tat, and Tat binding to TAR, while detectable, is very inefficient in the
absence of CycT1. It is conceivable that the CycT1-Tat heterodimer directly binds to
TAR RNA in the U-rich RNA bulge region and this binding facilitates the interactions of
the CycT1-Tat heterodimer to the O6 and N7 functional groups at nucleotide positions
32 and 34 in the RNA loop region (Richter et al., 2002). Heterogeneous
ribonucleoprotein C1 and C2 (hnRNP-C1/C2) bind U tracts. Using the yeast-three
hybrid system, Koloteva-Levine et al. have shown that hnRNP-C1 and -C2 binding to U
tracts is sequence dependent (Koloteva-Levine et al., 2002). The 3' UTR of the mouse
Cas-1 mRNA, encoding the antioxidant enzyme catalase, has a U-rich motif that is
conserved across species. This motif is an active site for complex and dynamic
interactions involving RNA-binding proteins. Proteins that bind to this motif have been
identified. One protein had a motif similar to the RNA recognition motif (RRM) protein
superfamily, implicated in splicing, stability, localization, and translation of RNAs
(Song and Singh, 2001). A cellular protein p36, identified as glyceraldehyde 3-
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phosphate dehydrogenase binds hepatitis delta virus (HDV) anti-genomic RNA. RNase
footprinting indicated that the UC-rich domain between nucleotides 379 and 414 of the
HDV antigenomic RNA was involved in the GAPDH binding (Lin et al., 2000). Insulin
like growth factor-1 (IGF-1) mRNA stability may be mediated by binding of certain
cytoplasmic proteins to the adenosine-uridine rich elements (AURE’s) present in the 3’
untranslated region (Hou et al., 2000). Uridine-rich sequences have also been identified
as protein binding sites for poly (A) polymerase from vaccinia virus (Deng and Gershon,
1997; Johnson and Gershon, 1999). AU-Rich elements in the 3' untranslated region of
epidermal growth factor receptor mRNA confer stability to the RNA, probably by
binding to proteins that stabilize the mRNA. These proteins are cellular proteins
identified by gel shift assays. The proteins bound only one of the AU-rich elements
present in the 3-cis acting element (Balmer et al., 2001). RNA-protein interactions are
also important in regulating the turnover rate of mRNA (Alterio et al., 2001). Bamboo
mosaic potexvirus satellite RNA (satBaMV RNA)-encoded P20 protein preferentially
binds to satBaMV RNA, primarily to the 5’ and 3’ –UTR’s.  Binding is competed out by
poly (U) and poly (G) sequences (Tsai et al., 1999).
Specificity of RNA binding
RNA sequence specificity for RNA binding proteins is critical for splice site
selection in RNA processing (Singh, 2002). Sequence specificity is exhibited in
nucleocapsid protein binding to viral RNA elements for packaging the viral genome
(Paoletti et al., 2002). Binding of E. coli glutaminyl-tRNA synthetase to its cognate
tRNA is a very specific interaction. In general, binding of the tRNA synthetase to the
29
3’end, requires certain identity determinants, such as base pairs in the acceptor stem and
the bases in the anti-codon loop, that contribute to specific interaction between the
synthetase and the tRNA leading to correct charging of the tRNA (Steitz et al., 1990).
Tertiary structure of RNA
Besides sequence specificity and secondary structure of the RNA, the steric
organization of bases is also important in RNA-protein interactions. The U73 binding
site for cysteine-tRNA synthetase is sterically optimized to accommodate a 2'-OH group
in the backbone, but the hydroxyl group itself is not involved in specific hydrogen
bonding interactions (Hou et al., 2001).  An aptamer based on glutamine tRNA in which
the five-nucleotide variable loop sequence 5'-44CAUUC48-3' is replaced by 5'-
44AGGU48-3’ bound glutaminyl-tRNA synthetase with a 30-fold improved affinity as
compared to the wild type tRNA. This suggests that enhanced protein binding to a
mutant globular RNA can arise from stabilization of RNA tertiary interactions rather
than optimization of RNA-protein contacts (Bullock et al., 2000).
OBJECTIVES
As a highly conserved protein, the N protein has been associated with multiple
functions in the viral replication cycle and is also a convenient diagnostic tool. It is not
known if phosphorylation can regulate the multiple functions of the N protein. Hence the
objectives of this study are:
A) To determine the phosphorylation status of the IBV N protein in infected cell lysates
and virion particles.
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B) To determine the ability of IBV N protein to form nucleocapsid-like structures in the
absence of other viral proteins.
C) To determine the significance of uridylates in N binding to viral RNA.
D) To develop a rapid ELISA technique using IBV recombinant N protein for detecting
IBV antibody in chickens.
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CHAPTER II
PHOSPHORYLATION OF THE IBV N PROTEIN
INTRODUCTION
Infectious bronchitis virus (IBV) is a prototype of the Coronaviridae family
(Collisson et al., 1992; Siddell et al., 1983). Coronaviruses are positive stranded RNA
viruses that primarily cause respiratory and enteric infections in a broad range of species.
Infection with IBV causes a highly contagious, respiratory disease in chickens with a
high mortality in young chicks. It also affects the genital and urinary systems (Alexander
et al., 1978; Crinion and Hofstad, 1972).
IBV has four structural proteins: membrane (M), spike (S), nucleocapsid (N) and
the small membrane (E) proteins. IBV N protein, 409 amino acids long, as that of other
coronaviruses is a basic, phosphorylated structural protein, that is highly conserved from
amino acid residues 238 to 293 (Hogue, 1995; Hogue and Brian, 1986; Wilbur et al.,
1986; Williams et al., 1992). The N protein directly binds viral genomic RNA and forms
a helical ribonucleoprotein complex (RNP) (Davies et al., 1981).  It has been implicated
in playing a role in genome replication, transcription of subgenomic RNA, translation
and in formation of the nucleocapsid (Masters et al., 1990; Masters and Sturman, 1990;
Tahara et al., 1998).
MHV N protein is the major protein synthesized almost four to five hours post-
infection in Sac (-) cells infected at a high multiplicity of infection (M.O.I.) (Siddell et
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al., 1980). In MHV, a 57 kilodaton (kDa) (p57) non-phosphorylated form is the
precursor to the 60 kDa (p60) phosphorylated form of the protein. p57 is present only in
the cytosol whereas, p60 is found associated with membranes as well (Anderson and
Wong, 1993). Anderson and Wong (1993) showed that single-stranded RNA and DNA
inhibit membrane binding of the N protein (Anderson and Wong, 1993).
Phosphorylation of coronavirus N protein
Two plaque morphology variants of JHM (strain of MHV), named DL and DS,
with minor differences in their RNA nucleotide fingerprints but with distinct
neurovirulence for mice, have been identified. Only two of the twenty-two serine-
containing tryptic peptides were found to be phosphorylated (Wilbur et al., 1986). In the
case of MHV, no differences in the tryptic peptide maps of the N-protein purified from
the virion, the infected cytosol and the infected cellular membranes were detected
(Wilbur et al., 1986). While two phosphorylated forms of the N-protein, 50 kDa and 55
kDa, were detected in BCoV infected cells, only the 50 kDa form was detected in the
virion.  Although the 55 kDa form was susceptible to calf intestinal alkaline phosphatase
(CIAP) treatment, the 50 kDa form was not susceptible to CIAP treatment (Hogue, 1995;
King and Brian, 1982).
The IBV N protein has been shown to be phosphorylated in infected cells
(Lomniczi and Morser, 1981). We show here that both the cellular and virion N proteins
are phosphorylated. It has been proposed that phosphorylation might regulate the
multifunctionality of the N protein (Masters and Sturman, 1990). We performed some
studies to determine the kinetics of phosphorylation and the variation in phosphorylation
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between the cellular and virion N proteins. Our work shows that IBV N is
phosphorylated at all times during infection. Our results suggest hat the IBV virion N
protein is more phosphorylated than the N protein present in infected cells.
MATERIALS AND METHODS
Virus and cells
The infectious bronchitis virus Beaudette strain, used for all experiments in this
study was propagated on Vero and chicken embryo kidney (CEK) cells in Dulbecco's
modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) or 10%
chicken serum respectively. Virus infections were carried out with DMEM containing 2%
serum.
Phosphate labeling of E.coli during expression of recombinant IBV N protein
An overnight culture of E.coli containing the recombinant IBV N gene expression
construct was grown at 37°C in Tris-glucose medium (120 mM Tris-Cl, 80 mM NaCl, 20
mM KCl, 20 mM NH4Cl, 3 mM Na2SO4, 0.2 mM CaCl2, 2 nM FeCl3 and 20% glucose)
containing 100 mM phosphate and 25 µg/ml kanamycin and 50 µg/ml ampicillin. This
culture was added to fresh Tris-glucose medium (without phosphate and with the above
mentioned antibiotics) to bring it to an optical density of 0.5. The bacteria were cultured
at 37°C on a shaker at 200 rpm for three hours. Protein expression was induced with
isopropyl-β-D-thiogalactopyranoside (IPTG) at a final concentration of 2 mM. The
bacteria were cultured for another five hours at 37°C on a shaker at 200 rpm in the
presence of 100 µCi/ml 32P-orthophosphate and the bacteria were harvested by
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centrifuging at 3000 g. The pellet was processed to purify the histidine-tagged-fusion-
proteins under native conditions as described in the Qiagen manual (Qiagen, Chatsworth,
CA). The purified protein was resolved by 15% SDS-PAGE analysis under denaturing
conditions.
Phosphate labeling during natural virus infection
Vero or CEK cells were infected with IBV Beaudette at a multiplicity of infection
(M.O.I.) between 2 and 3 for one hour. Fresh DMEM containing 2% serum was used for
virus-infected cells. For one hour prior to labeling with 100 µCi 32P-orthophosphate, cells
were starved in phosphate-free DMEM containing 2% phosphate-free serum. The cells
were labeled for one hour. The cells were washed with Tris buffered saline (TBS)
(Sambrook et al., 1989) and either 0.5 ml of modified lysis buffer [1 mM iodoacetamide,
1 mM phenyl methyl sulfonyl fluoride (PMSF), 100 µM sodium orthovanadate, 4 µg/ml
aprotinin, 1 mM EDTA, 1% NP40, 10 mM Tris (pH 8), 0.1% SDS, 150 mM NaCl and
0.025 % sodium azide] was added to the 60 mm dishes or 1 ml lysis buffer was added to
the 100 mm dishes (Sefton et al., 1978). Cells were scraped off the dish surface and lysis
was carried out at 4°C for 30 minutes. The sample was used for immunoprecipitation of
IBV N protein. Protease inhibitors PMSF, EDTA, and aprotinin were added to the lysis
buffer to prevent protease digestion of proteins. The serine/threonine phosphatase
inhibitor sodium fluoride and tyrosine phosphatase inhibitor sodium orthovanadate were
used in the lysis buffer to prevent the loss of labeled phosphate from the N protein in the
lysate.
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Pulse-chase analysis
Vero cells were infected with IBV Beaudette strain at an M.O.I. between 2 and 3
for one hour after which fresh DMEM containing 2% serum was added. To determine
the stability of IBV N protein at 6.5 hours post-infection (h p.i.), 2 ml of hypertonic
medium containing 2% serum (DMEM containing 0.335M NaCl) were added to the cells
to dissociate the ribosomes and thereby synchronize the cells for protein synthesis. After
one hour (7.5 h p.i.), the hypertonic medium was discarded and the cells were washed
with phosphate buffered saline (PBS) (Sambrook et al; 1989) and 1 ml serum-free,
methionine-free DMEM (Gibco, Carlsbad, CA) containing 100 µCi 35S-methionine was
added to the virus-infected cells. Labeling was carried out for 30 minutes followed by
chase as described below. To determine the phosphate turnover of IBV N protein, one
hour prior to labeling the virus-infected cells with 100 µCi 32P-orthophosphate (for a
period of one hour), the cells were washed with TBS and starved in phosphate free
DMEM containing 2% serum (phosphate free).
35S and 32P pulsed cells (above) were chased by removing the labeling medium,
washing the cells with PBS, and adding 3 ml of chase medium, either DMEM containing
2% serum and 1 mM L-methionine or DMEM containing 2% serum and 10 mM
phosphate buffer for 35S and 32P pulses, respectively. The cells were chased for 2.5 or 3
hours depending on the experiment. At the end of the chase period, the cells were
washed with PBS and 0.5 ml of lysis buffer was added to the plate after scraping the
cells with a rubber policeman. The cells were lysed for 30 minutes at 4°C and processed
for immunoprecipitation.
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Immunoprecipitation of the IBV N protein
The lysates were centrifuged at 1000 g to pellet the nuclei and cell debris. Rabbit
anti-N polyclonal antibody was added to the lysate at saturating concentrations to
precipitate all the N protein. The mix was incubated on a shaker at 4°C for one hour. 50
µL of a 50% slurry of protein-A-agarose (Pierce, Rockford, IL) in dilution buffer {10
mM Tris, pH 8; 140 mM NaCl; 0.025% sodium azide (Tris saline azide) and 1% NP40}
were added to capture the antigen-antibody complex. This mix was incubated at 4°C for
one hour. The protein-A-agarose antigen-antibody complex was washed thrice with TSA
and eluted by adding 20 µl of 2X SDS-PAGE loading buffer and heating at 100°C for 10
minutes. The sample was resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (Sambrook et al., 1989). Following electrophoresis, the
gels were dried and exposed to an imaging plate (Fuji Medical Systems, Stamford, CT)
or to an X-ray film. Band intensity was quantified using a Fuji2000 phosphorimager
(Fuji Medical Systems, Stamford, CT) and represented as photostimulus luminescence
(PSL) units. Phosphate and protein stability was represented as percent PSL units
measured in comparison to the maximum incorporation of radioisotope in the
immunoprecipitated protein.
Western blot analysis
After resolving the proteins by denaturing gel electrophoresis, the proteins were
transferred from the gel to a nitrocellulose membrane (Sambrook et al., 1989). The
membrane was blocked with blocking solution (5% skim milk 0.02% tween 20 in TBS)
for two hours at room temperature (R.T.). Chicken anti-IBV Gray (strain of IBV)
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antibody (1:1000 dilution in blocking solution) was added to the blot and allowed to
react with the proteins for one hour at R.T. After two washes with washing buffer (TBS-
0.02% Tween 20), alkaline phosphatase conjugated goat anti-chicken antibody (KPL)
(1:10,000 dilution in blocking solution) was added to the blot and allowed to react for
one hour at R.T. After two washes with washing buffer, alkaline phosphatase substrate,
5-bromo-4-choloro-3-indolyl phosphate (BCIP) and nitroblue tetrazolium (NBT),
alkaline phosphatase conjugate substrate (Bio-Rad, Richmond, CA) was added to the
blot for color development. The substrate was removed and the blot was washed after
color development.
Double labeling of IBV N protein   
One hour prior to labeling, virus-infected Vero or CEK cells were starved of
leucine and phosphate in serum-free, leucine and phosphate-free DMEM (Specialty
Media, Phillipsburg, NJ). Cells were labeled with 100 µCi 32P-orthophosphate and 10
µCi 3H-leucine (Perkin Elmer, Wellesley, MA) for one hour. At the end of the labeling
period, the cells were harvested as described above and IBV N protein was
immunoprecipitated using rabbit anti-N polyclonal antibody. RNA was extracted from
the protein using TRIZOL. DNA associated with the protein was removed by
precipitating with 0.3 volumes of 100% alcohol per 1 ml of TRIZOL Reagent. IBV N
protein was isolated from the organic phase by precipitating with isopropyl alcohol
(Invitrogen, Carlsbad, CA). The precipitate was dissolved in 2X SDS-PAGE gel loading
buffer and used for TCA precipitation to determine the 3H and 32P counts per minute
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(cpm) (Ausubel et al., 1987). 32P:3H ratios were calculated. The experiments were done
in duplicate.
Purification of IBV virion
Virus from supernatants of five 100 mm tissue culture plates infected at an M.O.I.
of 2 to 3, were concentrated on a 20% sucrose cushion, by centrifuging at 35,000 rpm in a
SW 55 Ti Beckmann rotor at 4°C for 2.5 hours. The virus pellet was suspended in 100 µl
TEN buffer (10 mM Tris pH 7.4, 1 mM EDTA, 150 mM NaCl) and centrifuged through a
linear 30%-50% glycerol-tartrate gradient at 35,000 rpm, in a SW 55 Ti Beckmann rotor
at 4°C for 18 hours. A distinct band corresponding to the virion was obtained around 1.18
g/ml density. The virus from this band was used for various analyses.
Alkaline phosphatase treatment
IBV N protein isolated from the infected cells or from virions after
immunoprecipitation with rabbit anti-N polyclonal antibody was dialyzed against PBS for
four hours at 4°C. Equal volumes of this dialyzed protein were used for treatment with
calf intestinal alkaline phosphatase (CIAP) (Promega, Madison, WI) and for the controls
(untreated IBV N protein and N protein treated with RNase A). The protein was treated
with 23 units of CIAP in 20 µl reaction volume. The reaction was incubated at 37°C for
30 minutes and stopped by heating at 70°C for 15 minutes. The protein was resolved by
15% SDS-PAGE followed by a Western blot with chicken anti-IBV Gray antibody
(Sambrook et al., 1989).
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Treatment of virus infected cells with serine-kinase inhibitor U0126
Virus-infected cells were labeled with 32P-orthophosphate and/or 3H-leucine as
described previously, for a period of one hour. The serine-kinase inhibitor U0126
(Calbiochem, San Diego, CA) was added to the virus-infected cells at a concentration of
10 µM or 20 µM when the cells were starved of phosphate and/or leucine. The inhibitor
was present throughout the labeling period until the cells were harvested for
immunoprecipitation of the IBV N protein. After isolating the IBV N protein, it was
resolved by electrophoresis in a denaturing 15% polyacrylamide gel (Sambrook et al.,
1989).
Protein preparation for mass spectrometry analysis
IBV N protein and bacterially expressed IBV recombinant N protein were
resolved by denaturing polyacrylamide gel electrophoresis and stained with Coomassie
brilliant blue R250 (Sambrook et al., 1989). The band corresponding to the N protein
was excised and cut into 1 mm-cubes and transferred to a 0.5 ml microfuge tube. The gel
pieces were washed with water (two changes) and with 50 mM ammonium bicarbonate
(NH4HCO3):acetonitrile 1:1 (v/v) for 15 minutes. The liquid was removed and enough
fresh acetonitrile to cover the gel particles was added to the tube. The acetonitrile was
removed once the gel pieces shrunk and stuck together. The gel pieces were rehydrated
in 50 mM NH4HCO3. After 5 minutes, an equal volume of acetonitrile was added to the
gel mix. All liquid was removed after 15 minutes and fresh acetonitrile was added to
cover the gel particles. Once the gel pieces have shrunk, the gel particles were dried in a
vacuum centrifuge.
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The gel particles were then rehydrated in 10 mM dithiothreitol/25 mM NH4HCO3
before incubating at 56°C for 45 minutes and chilling to room temperature. The excess
liquid was removed and replaced with roughly 150 to 200 µl of freshly prepared 55 mM
iodoacetamide in 25 mM NH4HCO3. The iodoacetamide solution was removed after
incubating the gel mix for 30 minutes at room temperature in the dark. The gel particles
were washed twice (15 minute intervals) with 50 mM NH4HCO3 and acetonitrile (1+1,
v/v) and after removing the wash fluid the gel pieces were shrunk by adding fresh
acetonitrile. The gel pieces were then dried under vacuum (Bruker, Billerica, MA).
For an in-gel digestion, enough sequencing grade trypsin (5 ng/µl) (Promega,
Madison, WI) freshly prepared in 25 mM NH4HCO3, was added to cover the gel and
digestion was carried out at 37°C for 30 minutes. 25 mM NH4HCO3 was added to cover
the gel pieces. After incubating at 37°C, the gel mix was sonicated for 10 minutes and
the supernatant recovered for analysis by matrix assisted laser desorption ionization-time
of flight spectrometry (MALDI-TOF) (Bruker, Billerica, MA).
The sample was cleaned and concentrated using a C18 Zip-Tip pipette tip
(Millipore, Billerica, MA) as per instructions given in the catalog. The matrix for
MALDI-TOF α-cyano-4-hydroxycinnamic acid (a-HCAA) was prepared in 33%
acetonitrile in 1% trifluroacetic acid (TFA). A 1:1 preparation of the sample or
calibration standard (Bruker, Billerica, MA) and matrix was applied to a Scout MTPTM-
384 ground steel target (Bruker, Billerica, MA) for MALDI-TOF analysis.
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MALDI-TOF analysis
The MALDI-TOF autoflex instrument (Bruker, Billerica, MA) was calibrated
using the ~ 1000 to ~ 4000 Da calibration standards in the linear mode. The
monoisotopic mass of the standards and the standards are as follows: Angiotensin II
(1046.54 Da), angiotensin I (1296.69 Da), substance P (1347.74 Da), bombesin (1620.81
Da), adenocorticotropic hormone (ACTH) (1-17) (2093.09 Da), ACTH (18-39) (2465.20
Da), somatostatin 28 (3147.47 Da). The “FLEXcontrol” software was used for
controlling the autoflex instrument. The tryptic peptide digest of IBV N protein was
analyzed using the autoflex MALDI-TOF instrument. The sample was ionized at ~ 60%
LASER. Analysis was in a linear acquisition mode. The spectrum was annotated and
monoisotopic peaks identified, providing lists of monoisotopic peak m/z values using the
“Xmass” software. The resulting peak lists were used for MASCOT database searching
using the “BIOTOOLS” software package (Bruker, Billerica, MA).
RESULTS
Phosphate labeling of the bacterially expressed recombinant IBV N protein
N protein expression was detected in E. coli when induced in Tris-glucose
medium. The protein, corresponding to an approximate molecular mass of 48 kDa
reacted with chicken anti-IBV Gray antibody in a Western blot assay (Fig. 2.1). A band
higher in electrophoretic mobility than the N protein also reacted with the antibody. This
is likely a breakdown product of the recombinant N protein (Fig. 2.1). 32P-
orthophosphate labeling in Tris-glucose medium of the E.coli expressed recombinant
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FIG. 2.1. Western blot analysis of recombinant IBV N protein from E. coli expressed in
Tris-glucose medium. Recombinant IBV N protein expression was induced in E. coli in
Tris-glucose medium and purified by Ni+2-NTA chromatography (Qiagen). The protein
was resolved by 15% denaturing SDS-PAGE analysis and reacted with chicken anti-IBV
Gray antibody. The N protein is marked by an arrow. The lower band is likely a
degradation product of the N protein.
48 kDa
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FIG 2.2. Calf intestinal alkaline phosphatase treatment (CIAP) of IBV N protein. 32P-
orthophosphate labeled IBV N protein from infected Vero cells and from the virion was
isolated by immunoprecipitation with chicken polyclonal anti-IBV antibody. Panel A,
shows the autoradiogram and panel B shows the Western blot. Virion N protein,
immunoprecipitated from lysates of uninfected cells, and cellular N protein were used
for the assay. The labeled N protein was treated with 20 units CIAP and resolved by
denaturing electrophoresis in a 15% polyacrylamide gel and subject to autoradiography.
Panel C, shows an autoradiogram of the virion N protein, panel D, an autoradiogram of
cellular N protein and panel E, a Western blot of cellular N protein. Cellular N was
obtained 8 h p.i.
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IBV N protein showed that the N protein was not phosphorylated in E. coli (data not
shown).
Alkaline phosphatase treatment of IBV N protein
32P-orthophosphate labeled IBV N-protein was isolated by immunoprecipitation
from IBV-infected Vero cells 8 hours post-infection (h p.i.) and from virions purified
from 32P-treated cells.  The virion N protein appeared to be slightly lower in
electrophoretic mobility than the cellular N protein as can be seen from the Western blot
(Fig. 2.2B). Both the intracellular and virion N proteins were phosphorylated (Fig.
2.2A). Two forms of the N protein are obtained from Vero cells both of which are
phosphorylated (Fig. 2.2A) as has been shown with virion N protein from chicken
embryo kidney (CEK) cells (Lomniczi and Morser, 1981). Both bands react with
chicken anti-IBV polyclonal antibody using Western blot analysis (Fig. 2.2B) suggesting
that the protein higher in electrophoretic mobility is either a degradation product or some
other isoform of the N protein. 32P-orthophosphate-labeled N proteins from infected cells
and virions were treated with calf intestinal alkaline phosphatase (CIAP), an enzyme that
removes phosphate from phosphoserine and phosphothreonine residues. The labeled
infected-cell N protein was susceptible to CIAP treatment as determined by
autoradiography, confirming the presence of phosphate on  the N protein from infected-
cell lysates. The cellular N protein loses its phosphate completely (Fig. 2.2D). The
Western blot confirms that IBV N protein was indeed present in the CIAP treated
immunoprecipitate from the cell lysate (Fig. 2.2E). Susceptibility of the virion N protein
to CIAP is indicated by a slight increase in mobility of the treated protein (Fig. 2.2C). It
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is possible that the alkaline phosphatase to substrate stoichiometry is higher in the virion
N protein than the N protein from infected cell lysates. The slight increase in
electrophoretic mobility in the case of the CIAP treated sample as compared to the
untreated sample might be due to the effect of CIAP or it might be due to the presence of
salts in the sample. It is not possible to estimate the amounts of the N protein in a
Coomassie stained gel because the heavy chain of the antibody and the N protein co-
migrate in a 15% polyacrymaide gel. In the phosphatase assay, the lower bands were not
visible even after a twenty-four hour exposure using a phosphorimager. To verify that
the band obtained in autoradiography was not due to the presence of labeled RNA bound
to the N protein, the N protein from both sources was also treated with 10 µg of RNAse
A. There was not a very apparent decrease in the intensity of the RNase A treated
samples as compared to the untreated controls (Figures 2.2C and 2.2D). This indicates
that either no RNA was associated with the IBV N protein from the cellular and virion N
protein or that the RNA was protected.
IBV N protein was phosphorylated at all times during infection
The kinetics of phosphorylation of IBV N protein has not been reported before. It
is possible that the N protein might not be phosphorylated at all times during IBV
infection. Hence, to determine if IBV N is phosphorylated throughout IBV infection,
IBV Beaudette-infected Vero cells were treated before and during labeling with 100 µCi
32P-orthophosphate for one hour with actinomycin-D (5 µg/ml) an inhibitor of RNA
synthesis. The IBV cellular lysate was obtained after TRIZOL (Invitrogen, Carlsbad,
CA) extraction to remove the labeled RNA bound to the proteins in the lysate. One-
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eighth the volume of the cell lysate was used for denaturing gel electrophoresis. As
shown by 32P-orthophosphate labeling, IBV N was the only phosphorylated viral protein
in infected cell lysates as can be seen by comparison with the uninfected cell lysate
control (Fig. 2.3A). IBV N was phosphorylated throughout infection, appearing around 6
hours post-infection until at least 18 hours post-infection, as represented by a
phosphorylated band at ca. 48 kilodalton (kDa) molecular mass (Fig. 2.3A). The other
phosphorylated band appearing slightly above 36.4 kDa was a cellular protein as it was
also present in the uninfected cell lysate control. Western blot analysis of a similar
experiment with rabbit anti-N polyclonal antibody was specific for IBV N protein that
corresponded to a band around 48 kDa molecular mass (Fig. 2.3B). It was noticed that
the mobility of the protein in the various lanes was not very uniform. This is probably a
gel artifact, perhaps due to insoluble material in the crude lysates or a stacking effect.
Pulse-chase analysis determined the stability of the IBV N protein
It was important to know the stability of IBV N protein before the stability of
phosphate on the N protein could be determined. IBV Beaudette-infected Vero cells
were pulse-labeled with 35S-methionine at 7.5 h p.i. before chasing with excess cold
methionine between 0.5 (8 h p.i.) and 3.5 hours (11.5 h p.i.) before harvesting the
infected cells. The IBV N protein was isolated by immunoprecipitation with rabbit anti-
N-polyclonal antibody at saturating concentrations of the antibody such that all N
protein in the infected cell lysate was precipitated. Since labeling the cells for 15 minutes
was unfruitful, the cells were instead pulsed for 30 minutes followed by the variable
chase period. Maximum incorporation of the label was observed after 1.5 hours of chase
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FIG. 2.3. Time-course of phosphorylation of IBV N protein in presence of actinomycin
D. Phosphorylation of IBV N protein in IBV-infected Vero cells was studied by labeling
with 100 µCi 32P-orthophosphate for one hour in the presence of 5 µg/ml actinomycin-
D. At different times post-infection (time is represented above the figure), equal amounts
of whole cell lysate from various time points were resolved by gel electrophoresis on a
15 % denaturing polyacrylamide gel followed by autoradiography. Lysate from an
uninfected (UN) cell was used as a control. IBV N is ca. 48 kDa in mass. Panel A,
represents a phosphorimage and panel B, represents a Western blot.
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FIG 2.4. Analysis of stability of IBV N protein. Panel A, represents a phosphorimage
and panel B, a graphical representation of the densitometric analysis of the bands
obtained in the phosphorimage. IBV-infected Vero cells were pulse-labeled with 25 µCi
35S-methionine for 30 minutes and chased with a large excess of cold methionine for 0,
0.5, 1, 1.5, 2, 2.5, 3 and 3.5 hours. The N protein was obtained from IBV-infected cell
lysates by immunoprecipitation with rabbit anti-N polyclonal antibody. 0 hour chase
time represents 8 hours post-infection. Lysates from uninfected cells precipitated with
rabbit anti-N polyclonal antibody (UN) and lysates from infected cell precipitated with
preimmune serum (PI) are also shown. Error bars represent standard deviations of two
densitometric measurements from one experiment.
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period (Figures 2.4A and 2.4B). As can be seen from the graphical representation of the
densitometric analysis of the bands using a phosphorimager (Fig. 2.4B), there was a
slight decrease in the intensity of the band until the 2.5-hour chase period followed by an
increase in the 3- and 3.5-hour chase-periods (Fig. 2.4A). The 2- and 2.5- hour chase
period band intensity corresponded respectively to 75% and 82% of the 1.5-hour chase
period band intensity. The 3- and 3.5- hour chase period band intensity corresponded
respectively to 85% and 92% of the 1.5-hour chase period band intensity. Since the
decrease in the band intensity was never greater than 50%, it is likely that the N protein
is stable for at least one or maybe two hours. N protein alone was precipitated as shown
by Western blot analysis using chicken anti-IBV Gray (strain of IBV) antibody (Figure
2.2B). No bands were obtained when lysates from uninfected cells were used for
immunoprecipitation using rabbit-anti-N polyclonal antibody (Figure 2.4A) or when
using non-specific antibody such as rabbit-anti-gag antibody to reticuloendotheliosis
virus (data not shown) were used as controls. A faint band slightly larger than 48 kDa
was obtained on exposure to an imaging plate when rabbit preimmune serum was used
for immunoprecipitation of infected cell lysates. This band does not react with anti-IBV-
Gray chicken serum as shown by the Western blot analysis (data not shown).
Pulse-chase analysis to determine the stability of phosphate on IBV N protein in
Vero cells
35S-methionine pulse-chase analysis indicated that the IBV N protein is stable
over at least a two-hour period. Phosphate on a protein can be removed very quickly or
slowly thereby regulating the function of the protein. In order to determine the stability
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FIG 2.5. Pulse-chase analysis to determine phosphate stability of IBV N protein. IBV
infected Vero cells were labeled with 32P-orthophosphate for one-hour and chased with
cold phosphate starting at 8 h p.i. until 11 h p.i. Panel A, represents a phosphorimage of
labeled N protein resolved by denaturing gel electrophoresis and panel B, represents the
densitometric analysis of the bands using a Fuji2000 phosphorimager. Error bars
represent standard deviations of two densitometric measurements from one experiment.
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of the phosphate on the N protein in terms of half-life, infected cells were labeled with
32P-orthophosphate for one hour and the chase analysis was started at 8 h p.i., and was
continued until 11 h p.i. N protein was immunoprecipitated from cell lysates at
saturating amounts of the antibody such that all the N protein precipitates out (this has
been standardized in the laboratory). From Figures 2.5A and 2.5B we can see that
phosphate incorporation continues to occur until the 1.5 h chase period, reaching a
maximum at the 2-hour chase period then drops down to 96% and 70% of this value in
the 2.5- and 3-hour chase period respectively. Since phosphate is utilized for several
processes in the cell, it might be more difficult to replace intracellular phosphate pools.
Labeling on the N protein might increase during the chase period due to labeled
phosphate from other cellular processes. This experiment has been done twice and
similar results were obtained at both times. From these results, the phosphate on the
protein does not fall below 70% in a one-hour chase period. This change in phosphate
level on the IBV N protein over a one-hour period might have, a positive, negative or no
effect on the various functions of the IBV N protein.
Determination of 32P-orthophosphate:3H-leucine ratios of IBV N protein
To determine variations in the amount of phosphate on the N protein during the
course of infection in the cell, infected cells were labeled with 3H-leucine and 32P-
orthophosphate. The ratio of the counts per minute (cpm) of 32P-orthophosphate:3H-
leucine gives an idea of the cpm of phosphate relative to IBV N protein. The ratios of
32P-orthophosphate and 3H-leucine on IBV N-protein were determined in IBV-infected
Vero and CEK cells. The 32P:3H cpm ratio for the virion (isolated at 16 hours post-
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infection), was almost 3.5 times and 10 times greater than the ratios obtained for the N
protein precipitated 7 hours post-infection from CEK cells and Vero cells respectively
(Table 2.1).
In order to establish the significance of difference between the 32P:3H ratios of
the N protein isolated at different times of virus infection and also establish the
significance of increasing trend with time in the proportions, we performed an
orthogonal polynomial contrast test across the time points. The various time points were
calculated as the treatment variable and the ratio was used as the response. A significant
linear trend (P<0.0001) in the ratios was obtained (Fig. 2.6). There is a direct correlation
in the amount of phosphate on the N protein with time. In order to establish a significant
difference in the 32P:3H cpm ratios of the N protein at various time points other multiple
comparison procedures were employed to analyze the data. The ratio (0.35 for CEK cells
or 0.24 for Vero cells) at time point 1 (7 hours post-infection) was significantly different
(P<0.05) from the ratio (1.22 for CEK cells or 2.52 for Vero cells) at time point 5 (16
hours post-infection) using Least Significant Difference (LSD) test. These results were
also confirmed by other multiple comparison procedures such as Student-Newman Keuls
test and Tukey’s Studentized Range test (Table 2.1).
Effect of a serine-kinase inhibitor U0126 on phosphorylation of IBV N protein
To determine the role of phosphorylation in the life cycle of the virus, specific
inhibitors of phosphorylation could be used. N protein has 33 serine, 18 threonine and 8
tyrosine residues. The sites of phosphorylation on this protein have not been identified
and hence site directed mutagenesis might prove a more tedious approach to determine
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Table 2.1.
Double labeling of IBV N protein in Vero and CEK cells to determine the ratios of
32P:3H on IBV N protein at different times of infection
Time of harvest:
hours post-infection (h
p.i.)
Chicken Embryo Kidney
cells: Ratio of counts per
minute (cpm) of 32P:3H
Vero cells: Ratio of
counts per minute (cpm)
of 32P:3H
7 0.35  ± 0.003 * 0.24 ± 0.003 *
9 0.83  ± 0.026 * 0.45 ± 0.002 *
11 0.80  ± 0.052 * 0.84 ± 0.001 *
13 0.73  ± 0.012 * 0.85 ± 0.04   *
16 (Virion N) 1.22  ± 0.003 * 2.52 ± 0.005 *
* Represents standard error values from two identical experiments.
Note. The results are representative of two experiments.
a) A significant linear trend (P<0.0001) in the ratios of 32P:3H on IBV N protein is
obtained, thus establishing the fact there is an increasing trend in the phosphate on the
N-protein with time.
b) The ratio at time point 1 (7 hours post-infection) is significantly different (P<0.05)
from the ratio at time point 5 (16 hours post-infection) using Least Significant
Difference (LSD) test.
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the role of phosphorylation of IBV N in the virus life cycle. Because of the large number
of serines, we decided to try specific kinase inhibitors to determine the role of
phosphorylation of IBV N protein in the virus life cycle. A preliminary analysis was
carried out with U0126, a specific serine-kinase inhibitor that inhibits the MEK 1 kinase
pathway. The consensus site of phosphorylation of this kinase was not known. N protein
from both the virion and the infected-cell lysates from Vero cells, treated with 10 µM
U0126, was decreased in phosphorylation as can been seen with double labeling studies
using 3H-leucine and 32P-orthophophate (Table 2.2). However, the difference in ratios
between the untreated and treated samples was not significant based on the one-tailed
equal variance T-test (P > 0.05). Concentrations higher than 10 µM inhibitor were found
to be toxic to the cells. To determine if this marginal effect on N protein phosphorylation
affected viral titers, the viral titers from inhibitor-treated and -untreated cells were
compared. Slightly higher titers were obtained from inhibitor-treated infected cells. This
difference was however not significant based on the T-test (P > 0.05) (Table 2.3). Hence,
this specific kinase inhibitor does not affect phosphorylation of IBV N protein nor the
virus titer in a significant manner. Other kinases possibly phosphorylate the IBV N
protein.
Matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass
spectrometry
The phosphorylation sites on the IBV N protein have not been identified. An
attempt was made at identifying phosphorylated peptides using MALDI-TOF mass
spectrometry. IBV N from bacteria expressing the recombinant N protein and from t
55
0
0.5
1
1.5
2
2.5
3
6 8 10 12 14 16 18
Hours Post-Infection
32
P
:3
H
 r
at
io
s 
cp
m
CEK cells
Vero cells
FIG 2.6. Graphical representation of 32P:3H cpm ratios of N protein obtained at different
hours post-infection from Vero- and CEK-infected cells. The N protein was obtained by
immunoprecipitation with rabbit anti-N polyclonal antibody. It was treated with
TRIZOL to remove bound RNA, followed by TCA precipitation to remove
unincorporated label and then counted to determine the 32P:3H cpm ratios. Standard error
is less than 0.05. A significant linear trend (P<0.0001) in the ratios was obtained.
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Table 2.2.
32P:3H ratios of IBV N protein in presence and absence of a serine-kinase inhibitor
U0126
Hours post-infection Untreated samples
Ratios of 32P:3H
Samples treated with 10
µM U 0126 serine-kinase
inhibitor. Ratios of 32P:3H
5 0.43 ± 0.12 * 0.36 ± 0.14 *
7 0.80 ± 0.14 *             0.68 ± 0.2 *
Virion             1.57 ± 0.2 * 1.45 ± 0.18 *
* Represents standard error values from two identical experiments.
The 32P:3H ratios of IBV N protein of the untreated and treated samples are not
significantly different as determined by the T-test (P>0.05).
Table 2.3.
Viral titers from IBV-infected Vero cells in the presence and absence of serine-kinase
inhibitor U0126
Inhibitor Viral titer (pfu/ml)
0 µM 6.3 x 107
10 µM   1.97 x 108
Viral titers were determined in triplicates and the average values are represented here.
The titers of the untreated and treated samples are not significantly different as
determined by the T-test (P>0.05).
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IBV virion was used for the analysis (Figures 2.7A and 2.7C). The band corresponding
to ca. 48 kDa for both, virion and bacterially expressed IBV N protein was excised from
the gel and used for sample preparation for MALDI-TOF analysis. The bacterially
expressed N protein always shows two bands, the lower band is thought to be a
degradation product as has been confirmed by Western blot analysis with chicken anti-
IBV Gray antibody (Fig. 2.7). Similarly, the N protein from lysates of infected Vero
cells has been shown to exist as two bands (Fig. 2.2B).
Predictably, recombinant IBV N protein expressed in bacteria was non-
phosphorylated (data not shown). Therefore it was used as a control for MALDI-TOF
analysis to compare the phosphorylated peptides obtained from the virion N protein.
MALDI-TOF mass spectrometry separates peptides based on the mass:charge ratio
(m/z). Trypsin is commonly used to digest the protein for peptide analysis. It digests
proteins after lysine or arginine amino acids residues. Using the Sequence Editor
software (Bruker, Billerica, MA), 67 tryptics were predicted varying in m/z from 288 to
3857 (Table 2.4). Immediately prior to analysis of the protein, the MALDI-TOF
instrument was calibrated using the 1000 to 4000 Da range peptide calibration standards
in the linear mode.  Either a quadratic (multipoint) or linear (two point) calibration can
be performed. A linear calibration employs only two peaks from the calibration
standards whereas a quadratic calibration can be configured to take into account multiple
peptides. A quadratic calibration is more accurate than a linear calibration because it can
interpolate and extrapolate more accurately. Preliminary MALDI-TOF analysis of the
virion N protein showed several peaks with a mass:charge (m/z) of less than 200.
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FIG. 2.7. SDS-PAGE and Western blot analysis of IBV N protein. Coomassie Brilliant
Blue R250 staining of the bacterially expressed protein is shown in panel A and of the
IBV virion is shown in panel C. Panel B, shows the Western blot of the bacterially
expressed N protein.
48 kDa
C
35 kDa
48 kDa
A B
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These can be ignored because they corresponded to single amino acid residues
obtainethe tryptic digest or ionized products of the matrix. For the virion N protein, very
few peaks were observed in the m/z range between 400-900. Ten peaks were obtained in
the range 1050-1500 and 9 peaks were obtained in the range 2000 to 2550. Peaks were
assigned to specific peptides by comparing predicted with actual m/z ratio. Many peaks
could not be assigned to a specific peptide because the m/z ratio did not correspond to
any of the predicted peptides that are obtained by trypsin digestion. The peaks obtained
here have an m/z ratio greater than that of the predicted peaks, suggesting a partial
digestion of the N protein. Only 4 peaks in the range of 400 to 1500 could be assigned
with certainty to peptides when compared to the predicted tryptic peptide digest obtained
with a zero partial cut (Fig. 2.8 and Table 2.4). GADVK (amino acids 120-124),
SGSEDDLIAR (amino acids 190-199), FSDGGPDGNFR (amino acids 144-154) and
VGSSGNASWFQAIK (amino acids 27 to 40) are shown in Figure 2.8 and Table 2.4.
Four other peptides were identified when a one or more partial cut was used for analysis
of predicted tryptic peptides. WDFIPLNR (amino acids 155-162), DPDKFDQYPLR
(amino acids 133-143), ALTSDEERNNAQLEFDDEPK (amino acids 376-395) and
SNQGTRDPDKFDQYPLR (amino acids 127-143) (Fig. 2.7). In the case of the IBV
recombinant N protein used as a control, four peaks in the ratio 399-450, and nine peaks
in the 820-1170 range could be assigned to peaks with certainty (Table 2.4.). Besides the
13 peaks that could be assigned to peptides, the other peaks obtained for the recombinant
IBV N protein had an m/z ratio greater than that of the predicted peaks, suggesting a
partial digestion of the N protein.
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Table 2.4.
Comparison of the mass:charge (m/z) ratios of predicted tryptic peptides (using the
Sequence Editor software) with a zero partial cut with that of the peptides identified
positively by MALDI-TOF analysis
Amino
acids
m/z Sequence Peak:
Recomb
-inant N
Peak:
Virion
N
1 43-43 146.106 K - -
2 210-210 146.106 K - -
3 362-362 146.106 K - -
4 368-368 146.106 K - -
5 73-73 174.112 R - -
6 84-84 174.112 R - -
7 189-189 174.112 R - -
8 226-226 174.112 R - -
9 230-230 174.112 R - -
10 248-249 203.127 GK - -
11 41-42 217.143 AK - -
12 217-218 217.143 AK - -
13 82-83 231.133 GR - -
14 163-164 231.133 GR - -
15 187-188 231.133 GR - -
16 246-247 247.153 TK - -
17 360-361 259.190 LK - -
18 125-126 261.144 SR - -
19 340-341 261.144 SR - -
20 363-364 275.148 EK - -
21 200-202 288.180 AAK - -
22 165-167 318.165 SGR - -
23 211-213 318.165 GSR - -
24 265-267 346.160 DGR - -
25 214-216 360.237 ITK - -
26 74-76 373.207 QAR - -
27 6-9 375.212 ATGK - -
28 365-367 399.259 RPK + -
29 227-229 412.178 YCK - -
30 357-359 430.229 QQR + -
31 287-290 443.274 VTPK + -
32 183-186 447.208 EGSR + -
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Table 2.4. (continued)
Amino
acids
m/z Sequence Peak:
Recomb
-inant N
Peak:
Virion
N
33 133-136 473.212 DPDK - -
34 120-124 488.259 GADVK - +
35 1-5 492.237 MASGK - -
36 77-81 575.343 FKPGK - -
37 127-132 661.314 SNQGTR - -
38 350-356 714.366 TSSPAPR - -
39 231-237 774.428 TIPPGYK - -
40 44-50 782.429 LNSPQPK - -
41 258-264 819.380 MNEEGIK - -
42 1-6 820.492 LGGPRPPK + -
43 333-339 827.402 DDEPKPK - -
44 219-225 828.335 ADEMAHR - -
45 369-375 847.356 QDDEVDK - -
46 342-349 860.446 SSSRPATR - -
47 203-209 871.476 IIQDQQK - -
48 250-257 880.356 EGNFGDDK + -
49 10-18 910.512 TDAPAPVIK - -
50 238-245 916.477 VDQVFGPR + -
51 376-383 919.425 ALTSDEER + -
52 137-143 937.466 FDQYPLR - -
53 155-162 1019.576 LQPDGLHLK - -
54 155-162 1059.550 WDFIPLNR + -
55 190-199 1061.499 SGSEDDLIAR + +
56 300-308 1094.576 FEFTTVVPR + -
57 64-72 1161.532 TSQQHGYWR + -
58 144-154 1167.495 FSDGGPDGNFR + +
59 309-318 1239.541 DDPQFDNYVK - -
60 384-395 1418.631 NNAQLEFDDEPK - -
61 168-182 1431.707 STAASSAASSRPPSR - -
62 51-63 1438.636 FEGSGVPDNENFK - -
63 27-40 1450.720 VGSSGNASWFQAIK - +
64 319-332 1489.702 ICDQCVDGVGTRPK - -
65 396-409 1515.721 VINWGDSALGENEL - -
66 268-286 2002.013 VTAMLNLVPSSHACLFGSR - -
67 85-119 3857.837 KPVPDAWYFYYTGTGPAADLN
WGDSQDGIVWVAAK
- -
(+ ) indicates peptides that were positively identified using MALDI-TOF
(-) indicates peptides that were not identified using MALDI-TOF
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FIG. 2.8. MALDI-TOF analysis of IBV virion N protein. Seven peptides of the virion N
protein that correspond to mass/charge (m/z) ratios as indicated in the figure are
represented here.
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Table 2.5.
Summary of the peaks assigned by MALDI-TOF analysis of the IBV N protein
Amino
Acids
Predicted
m/z value
Observed
m/z
∆ m/z Sequence
A 190-199 1061.5 1062.084 0.585 SGSEDDLIAR
B 144-154 1167.5 1168.988 1.493 FSDGGPDGNFR
C 155-162   1059.55 1061.074 1.329 WDFIPLNR
D 133-143   1392.67 1393.976 1.524 DPDKFDQYPLR
E 27-40   1450.67 1452.049 1.309 VGSSGNASWFQAIK
F 376-395     2320.046 2322.037 1.991 ALTSDEERNNAQLEFDDEPK
G 120-124       488.259   489.284 1.025 GADVK
H 127-143     2037.154 2037.606 0.452 SNQGTRDPDKFDQYPLR
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FIG. 2.9. Scatter plot comparing the predicted and obtained values of m/z ratios of some
of the assigned peaks in the MALDI-TOF spectrum of the IBV virion N protein.
∆
  190-199   144-154  155-162  133-143   27-40    376-395  120-124  127-143
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SGSE is a potential casein kinase II phosphorylation motif. Since the peptide
constituting amino acids 190-199 was not phosphorylated, the serine in this motif is not
phosphorylated. This motif was absent in the other peptides that were assigned. For the
virion N protein, a scatter plot of the ∆ m/z values between the predicted and observed
m/z of the assigned peaks obtained from the spectrum is presented in figure 2.9. As can
be seen the difference between the two values is marginal. The difference between the
predicted and obtained values ranges between 0.585-1.99 Da (Table 2.5). Similar
differences in m/z ratios were obtained with the recombinant IBV N protein as well (data
not shown). Under the conditions tested, phosphorylated peptides of IBV N could not be
identified.
DISCUSSION
Coronavirus N proteins are known to be phosphorylated, although the precise
sites have not been identified and  the mechanism regulating the functions of the N
protein are not known. It has been postulated that phosphorylation might control the
multiple functions of the N protein (Siddell et al., 1995). Coronavirus N has been
implicated in transcription, replication, translation and packaging of the viral genome
(Siddell et al., 1995). With an M.O.I. of 5, synthesis of MHV N protein begins around
4.5 hours post-infection (h p.i.) as determined using 35S-methionine labeling (Cheley and
Anderson, 1981). With an M.O.I. between 2 and 3, we find that IBV N protein synthesis
can be detected around 6 hours post-infection by Western blot analysis and the N protein
was phosphorylated by 6 h until at least 18 h, while cytopathic effect was observed by 14
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h p.i. It is possible that differential phosphorylation might regulate the various functions
of the N protein. The best way to investigate whether the IBV N is differentially
phosphorylated is to isolate the N protein from the infected cell lysates at varying times
during infection and identify the sites of phosphorylation by mass spectrometric
analysis.
Unlike the MHV N protein, that is stable for one hour, from the results of a 35S-
methionine pulse-chase experiment; the IBV N protein was stable for at least a two-hour
period (Perlman et al., 1986). The stability of phosphate on the N protein might give an
indication of how quickly it is removed from the protein. The phosphate on the protein
might be present for very long periods or it might be removed very quickly. Our results
show that the labeled phosphate on the protein reached a maximum level of
incorporation only when chased for two hours which is probably due to a delay in
chasing the intracellular phosphate pool, and then the level dropped down to 70% of this
maximum value when chased for another hour. It is possible that even this change in the
level of phosphorylation might affect the function of the IBV N protein. It is also likely
that differential phosphorylation actually regulates the functions of the IBV N protein.
The IBV N protein for the pulse-chase analysis experiments was isolated by
immunoprecipitation using saturating amounts of rabbit polyclonal antibody to the N
protein such that it precipitated both labeled and unlabeled N protein from infected cell
lysates. All analyses were carried out based on duplicate sets of experiments and gave
nearly identical results.  MHV M has been shown to co-precipitate with N using anti-
MHV N monoclonal antibody (Narayanan et al., 2000). With BCoV, rabbit polyclonal
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antibody to N does not co-precipitate M in infected cells (Nguyen and Hogue, 1997). In
our experiments, no other proteins co-precipitated with IBV N using the rabbit-anti-N
polyclonal antibody. This may be due to differences in the cell type, lysis buffer, as well
as antibody used for immunoprecipitation.
 Double labeling studies with 32P-orthophosphate and 3H-leucine suggest that the
virion N protein is more phosphorylated than the cellular N protein. The 32P:3H cpm
ratio of the virion N protein from Vero cells is greater than the ratio from CEK cells. A
small difference in electrophoretic mobility between the virion and cellular N protein,
with the virion N protein of slightly greater molecular mass, is observed by SDS-PAGE
analysis indicative of additional modification of the virion N protein. In the case of
measles virus, nucleoprotein phosphorylated on both serine and threonine is
preferentially assembled into the nucleocapsids (Gombart et al., 1995). Consistent with
our results, greater phosphorylation possibly increases the binding of N protein to viral
RNA for packaging or assembly into nucleocapsids. In the case of Chandipura virus,
homodimerization of the phosphoprotein (P) protein occurs via the N-terminal 46 amino
acids of the protein and occurs only after phosphorylation of this region (Raha et al.,
2000). A global conformational change in the N-terminal domain of the P protein is
induced by phosphorylation (Raha et al., 1999). It is possible that phosphorylation of the
IBV N protein induces some kind of a conformational change thereby promoting N-N
interaction. This N-N interaction may be important in RNA binding, in nucleocapsid
assembly and in compacting the nucleocapsid. Narayanan et al. (2003) showed that the
MHV N protein in the virion nucleocapsid and in the intracellular genome-length RNP
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complexes that bound to the viral M protein was tightly self-associated, such that its
association was retained even after extensive RNAse A treatment. This was not the case
with RNP complexes formed with subgenomic RNA (Narayanan et al., 2003b). It is
highly likely that the hyperphosphorylated form of the IBV N protein binds genomic
RNA in association with other viral proteins thereby forming tight complexes that are
compact and resistant to RNase A treatment. Phosphorylation of the N protein might
also affect IBV infectivity. A protein kinase activity was found associated with purified
virus preparations of MHV, indicating the presence of a kinase in the virion (Siddell et
al., 1981). Studies carried out with JHM strain of MHV (JHMV) showed that
dephosphorylation of the nucleocapsid protein of JHMV may be essential for initiating
the virus replication cycle (Kalicharran and Dales, 1995). In the case of cauliflower
mosaic virus, mutation of the capsid protein phosphorylation sites from serine to alanine
abolished infectivity (Chapdelaine et al., 2002). As suggested earlier, the
hyperphosphorylated form of the protein might be required for the formation of a
compact nucleocapsid. It is possible that dephosphorylation of the N protein might
therefore be required to unravel the nucleocapsid making the genome more accessible to
RNA dependent RNA polymerase. The 32P:3H cpm ratio of the IBV virion N protein
from Vero cells is 7 times more than the ratio of the virion N protein from CEK cells.
CEK cells are primary cells whereas Vero cells are a cell line. Also, Vero cells are
primate kidney cells and CEK cells are avian kidney cells. There might be a higher level
of activity of kinases in the cell line that contribute to these observed differences. CEK
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cells produce interferon whereas Vero cells do not produce interferon. Hence, the
differences between the cell types might cause this variation.
Viral proteins have been shown to be phosphorylated in vitro by casein kinase II
(Bontems et al., 2002). Based on sequence gazing, two potential casein kinase II and
four potential cAMP and cGMP dependent protein kinase phosphorylation sites were
identified on the IBV N protein. In order to determine the sites of phosphorylation,
MALDI-TOF mass spectrometry analysis was performed with the IBV virion N protein.
With the recombinant IBV N protein expressed in bacteria, 13 tryptic peptides could be
assigned to peaks. A partial tryptic digest was obtained with the bacterially expressed
protein. In the case of the virion N protein, due to a partial tryptic digest, only eight
tryptic peptides could be assigned in the MALDI-TOF spectrum and none of these were
phosphorylated. For future analysis the following points need to be considered. Very few
peaks of predicted peptides in the m/z range of 400 Da to 900 Da were obtained in the
analysis, possibly due to ion suppression which is a phenomenon where the presence of
salts, detergents, urea, glycerol or too much of starting sample can interfere in the
formation of ions. Even if the protein is digested into peptides, these non-ionized species
cannot reach the detector. A partial digest could also result in a situation where predicted
tryptic peptides are missing from the MALDI-TOF spectrum. Approximately 200 ng of
N protein were used in our analysis. Since the IBV N protein is rich in lysine and
arginine residues, a higher trypsin:substrate stoichiometry or a longer digestion time
should be employed to ensure a complete digest. In our analysis, several peaks were
obtained in the m/z ratio of less than 200 Da. This might have been due to the use of a
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high laser output power. However, effective use of laser power is required to achieve
ionization of all peptides especially the larger ones. Calibration of the instrument is also
critical in the analysis of the results. We used a linear calibration that identified predicted
peptides in the MALDI-TOF spectrum that were greater by mass between 0.585-1.99
Da. In the future, the use of a quadratic calibration will give more accurate results of m/z
ratios over the range of the standards used. Several modifications of amino acids occur
during sample preparation, which change the m/z ratio of the peptide. These mass
differences must be taken into account when carrying out the analysis. Commonly
occurring modifications are change of N to D, oxidation of methionine and conversion
of cysteine to Carbamidomethyl, Carboxymethyl, Propionamide or S-pyridylethyl.
Kinase inhibitors have been used to determine the role of phosphorlyation in the
virus life cycle. Kinases affect various cellular functions and hence the use of inhibitors
to kinases is likely to have either a direct or indirect or no effect on the virus life cycle.
In our studies, U0126, a specific serine-kinase inhibitor did not have any effect on the
phosphoryaltion of the IBV N protein.
An infectious cDNA clone has now been constructed (Youn, 2003) and is also
readily available. Once the N protein phosphorylation sites have been identified site-
specific mutagenesis is a more appropriate approach to determine the role of IBV N
protein phosphorylation in the virus life cycle.
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CHAPTER III
INFECTIOUS BRONCHITIS VIRUS BACTERIALLY EXPRESSED
RECOMBINANT NUCLEOCAPSID PROTEIN PRODUCES HELICAL
STRUCTURES IN THE ABSENCE OF OTHER VIRAL STRUCTURAL
PROTEINS
IBV has four structural proteins: the spike (S) protein that is important in cell
entry, the membrane (M) protein that can interact with the small envelope (E) protein to
form virus-like particles and the nucleocapsid (N) protein that binds the viral genome to
form a helical nucleocapsid (Davies et al., 1981; Lomniczi and Morser, 1981;
Macnaughton and Madge, 1977). The M protein is the most abundant glycoprotein in the
virus (Siddell et al., 1995). The E protein is present in very small amounts in the infected
cell as well as in the virion.  Virus assembly requires the interaction of the helical
nucleocapsid with the M, E and S proteins to form the complete virus (Spaan et al.,
1981; Stohlman et al., 1983). M and E proteins interact with each other and also with the
S protein. M also interacts with the N protein as has been shown by co-
immunoprecipitation in MHV and BCV infected cells (Corse and Machamer, 2003;
Escors et al., 2001; Kuo and Masters, 2002; Narayanan et al., 2000; Nguyen and Hogue,
1997). The N protein binds genomic as well as subgenomic RNA as shown by
immunoprecipitation studies (Stohlman et al., 1988). Although subgenomic RNA is
packaged in very small amounts in IBV and TGEV, the genome is the predominant
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packaged RNA in coronaviruses. The presence of a packaging signal sequence has been
shown to confer packaging of non-viral RNA in TGEV, MHV and BCV. This sequence
is present at the 3’ end of the pol 1b region in BCV and MHV and in the 5’- untranslated
region in TGEV (Cologna and Hogue, 2000; Escors et al., 2003; Woo et al., 1997). The
MHV M protein can bind this sequence in the absence of the N protein. It is speculated
that the M protein is responsible for the specificity of packaging (Narayanan et al.,
2003a; Narayanan et al., 2000; Vennema et al., 1996).
Although it is not known if formation of the helical nucleocapsid requires the
presence of other viral structural proteins, nucleocapsid proteins have a tendency to
oligomerize, a property that is important for assembly into a nucleocapsid (Alfadhli et
al., 2001; Baron and Forsell, 1991; Sandalon and Oppenheim, 1997; Wootton and Yoo,
2003). Nucleocapsid proteins of measles virus, rabies virus, Newcastle disease virus,
human immunodeficiency virus (HIV) and respiratory syncytial virus (RSV) form
nucleocapsid-like structures when expressed in E. coli or Sf9 cells. RNA has been found
associated with the nucleocapsid-like structures formed by the heterologous expression
of the nucleocapsid proteins of these viruses (Errington and Emmerson, 1997; Fooks et
al., 1993; Gross et al., 1997; Iseni et al., 1998; Murphy et al., 2003). Herein, electron
microscopy results show that recombinant IBV N protein expressed in E. coli also forms
nucleocapsid-like structures that resemble extended nucleocapsid structures isolated
from the virus.
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MATERIALS AND METHODS
Expression and purification of the IBV recombinant nucleocapsid (N) protein and
N protein polypeptides
The N gene and several truncations of the N gene were cloned into the pQE8
vector and expressed as a histidine tagged protein in E. coli M15 cells (Zhou et al.,
1996). Fifty ml of an overnight culture of bacteria grown in SOC medium (Sambrook et
al., 1989) containing 50 µg/ml ampicillin and 25 µg/ml kanamycin were inoculated into
450 ml SOC medium containing the same antibiotics. The bacteria were cultured at 37°C
on a shaker at 200 rpm for three hours. Protein expression was induced with IPTG at a
final concentration of 2 mM. The bacteria were cultured for another five hours at 37°C
on a shaker at 200 rpm and harvested by centrifuging at 3000 g. The pellet was
suspended in non-denaturing buffer (0.05 M Tris, pH 8, 0.3 M NaCl, 0.01 M imidazole).
Lysozyme was added at a final concentration of 0.1 mg/ml and the sample was incubated
on ice for 30 minutes. The sample was lysed on ice by sonication at a 100 W power
output, 10 s pulses, six times with 10 s intervals. The sample was centrifuged at 5000
rpm at 4°C for 10 minutes, in a JA 21 rotor. The supernatant was collected and 1 ml of a
50% Ni+2-NTA resin (Qiagen, Chatsworth, CA) was added to every 10 ml of cell lysate.
The mix was incubated on a shaker at 4°C for one hour. The resin was collected by
centrifuging at 1800g, in a Joun CR412 centrifuge at 4°C for 1 minute and washed three
times with 10 ml of wash buffer (0.05 M Tris, pH 8, 0.3 M NaCl, 0.02 M imidazole).
The protein was eluted from the resin with 1 ml of elution buffer (0.05 M Tris, pH 8, 0.3
M NaCl, 0.25 M imidazole). Approximately 3 mg of N protein were obtained per 500 ml
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of bacterial culture. Polypeptides equal to, or greater than, 274 amino acids were further
purified by gel permeation chromatography using a Sephadex G200 (16/100 column
specifications) (Sigma, St. Louis, MO) or Superdex 200 (16/60 column specifications)
(Amersham Biosciences, Piscataway, NJ) column while peptides equal to or smaller than
207 amino acids were purified with Bio-gel P60 (Bio-Rad, Richmond, CA) in a column
of 1.6cm inner diameter and 100cm length. Five ml of each sample were loaded onto the
column before washing with Tris buffer (Tris 0.05 M pH 8, 0.3 M NaCl). Fractions were
monitored with the Bio-Rad protein assay reagent (Bio-Rad, Richmond, CA), and the
fractions containing protein, were analyzed by 15% polyacrylamide gel electrophoresis
(Sambrook et al., 1989). Protein used for electron microscopy was dialyzed in HEPES
buffer (25 mM HEPES, 25 mM EDTA, 150 mM NaCl, 5 mM DTT and 5% glycerol).
Western blot assays were used to determine the viral specificity of the
recombinant polypeptides (Sambrook et al., 1989). Briefly, varying amounts of the
proteins were separated by 15% polyacrylamide gel electrophoresis and blotted onto
nitrocellulose membranes. After blocking the membranes with 5% skim milk in Tris
buffered saline (TBS, pH 7), the membranes were reacted sequentially with chicken anti-
IBV Gray serum and alkaline phosphatase conjugated goat anti-chicken IgG (KPL,
Gaithersburg, Maryland).
Electron microscopy of IBV N protein and N polypeptides
Specimen preparation was performed according to Valentine (1968) and the
droplet on the grid method (Hoppert and Holzenburg, 1998). For the droplet method, 5
µl of various protein preparations in HEPES buffer (25 mM HEPES, 5 mM EDTA, 150
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mM NaCl, 5 mM DTT, 5% glycerol) at a concentration of 0.1 mg/ml were placed on
glow-discharged carbon-formvar coated copper grids for 30 s. The excess liquid was
blotted, and the grids were washed with distilled water. Samples were negatively stained
using a 2% (w/v) aqueous solution of uranyl acetate. Specimens were observed using a
JEOL 1200 EX transmission electron microscope at an acceleration voltage of 80 kV
and micrographs were recorded at a calibrated magnification of 40,000.
An attempt was made at obtaining monodisperse, single particles of the IBV full-
length N protein. HEPES buffer (25 mM HEPES, 5 mM EDTA, 150 mM NaCl, 5 mM
DTT, 5% glycerol) with various concentrations of magnesium (10 mM, 20 mM, 40 mM,
50 mM, 60 mM, 70 mM, 80 mM, 90 mM and 100 mM) ions were incubated for 20
minutes at room-temperature following which the samples were used for N protein
preparation for electron microscopy.
Thin sections of E.coli expressing the IBV recombinant N protein
Induced and uninduced bacterial preparations were fixed in 2.5% glutaraldehyde
in 0.1 M sodium cacodylate-HCl buffer, pH 7.4 for 1 hour at room temperature (R.T.).
The bacterial specimens were then pelleted by centrifugation and washed 3X, 15 min
with 0.1 M cacodylate buffer, pH 7.4.  Pellets were post fixed overnight at 40°C with 1%
osmium tetroxide in 0.1 M cacodylate buffer, pH 7.4.  Pellets were washed with 0.1 M
cacodylate buffer followed by dehydration in an ethanol series (20, 40, 60, 80, 90, 100%
X 2) to propylene oxide.  Specimens were then infiltrated and embedded in Araldite-
Quetol 651 epoxy resin (Ellis, 2002).  Ultra thin sections on 200 mesh copper grids were
post stained with 2% aqueous uranyl acetate followed by Reynolds lead citrate
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(Reynolds, 1963). Grids were examined and photographed at an accelerating voltage of
80 kV in a JEOL 1200 EX transmission electron microscope (TEM).
Isolation of radiolabeled RNA from IBV recombinant N protein
An overnight culture of E. coli containing the N gene expression construct was
grown in Tris-glucose medium (Tris 120 mM, NaCl 80 mM, KCl 20 mM, NH4Cl 20
mM, Na2SO4 3 mM, MgCl2 1 mM, CaCl2 0.2 mM, FeCl3 2 mM and Glucose 20%)
containing 100 mM phosphate and 25 µg/ml kanamycin and 50 µg/ml ampicillin at 37°C
at 200 rpm on a shaker. This culture was added to fresh Tris-glucose medium (without
phosphate and with the above mentioned antibiotics) to bring it to an optical density of
0.5. The bacteria were grown at 37°C on a shaker at 200 rpm for three hours following
which protein expression was induced with isopropyl-β-D-thiogalactoside (IPTG) at a
final concentration of 2 mM. The bacteria were cultured for another five hours at 37°C
on a shaker at 200 rpm in the presence of 100 µCi/ml 32P-orthophosphate and the
bacteria were harvested by centrifuging at 3000 g. The pellet was processed to purify the
histidine-tagged-fusion-proteins under native conditions as described in the Qiagen
manual (Qiagen, Chatsworth, CA). RNA was extracted from the N-protein using
TRIZOL (Invitrogen, Carlsbad, California) and analyzed by denaturing agaorse gel
electrophoresis. Following electrophoresis the gel was dried and exposed to an imaging
plate (Fuji Medical Systems, Stamford, CT). RNA from E.coli DH5α lacking any
vector, induced with IPTG and RNA from uninduced E.coli containing the N gene
expression construct were used as controls. The procedure for RNA isolation from the
controls was identical to that of the test.
77
RESULTS
Protein preparation
Full length IBV N and its truncation mutants were expressed in E. coli (Zhou et
al., 1996). N represents whole IBV N protein, N91 represents amino acids 1 to 91, N171
represents amino acids 1 to 171, M173 represents amino acids 101 to 283, C207
represents amino acids 203 to 409 and C140 represents amino acids 268 to 407 of IBV N
protein respectively (Fig. 3.1). The polypeptides were used to identify an RNA binding
region of the IBV N protein (Zhou et al., 1997). Recombinant polypeptides were first
purified by Ni2+-NTA chromatography. SDS-PAGE indicated that the samples eluted
from the Ni2+-NTA resin were impure (Fig. 3.2). Therefore, N and C207 were further
purified with Superdex-200 and Sephadex G-200 respectively, and polypeptides equal to
or less than 171 amino acids, C140 and N171 were further purified with a Bio-gel P60
column (Zhou et al., 1996). The column matrices were selected based on the ability to
resolve proteins depending on molecular mass.
The further purified proteins were analyzed by SDS-PAGE. Qualitative analysis
of each sample showed that the samples contained the polypeptide of expected
molecular weight. C207 and full-length N (Fig 3.3) contained additional proteins slightly
smaller than the expected molecular weight. The smaller peptides also reacted with the
chicken anti-IBV Gray polyclonal antibody in Western blot analyses (data not shown).
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FIG. 3.1. IBV N protein and N-based polypeptides expressed in E. coli. Peptides
corresponding to the amino terminus and carboxyl terminus are designated . Full-length
IBV N is approximately 48 kDa in molecular mass. The predicted molecular mass of N-
based polypeptides is given in parenthesis. The number following N, C, and M
correspond to the length, in amino acid residues, of the polypeptides. All fragments had
an N-terminal polyhistidine tag from the expression plasmid (Qiagen, Chastworth, CA).
Nucleocapsid protein (N)
1 91
N91 (10.78 kDa)
1 171
N171 (19.58 kDa)
M173 (20.79 kDa)
101 283
203 409
C207 (23.43 kDa)
C140 (16.06 kDa)
268 407
1 409
Amino terminus (N) Carboxyl terminus (C)Middle region (M)
48 kDa
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FIG. 3.2. SDS-PAGE analysis of IBV N and polypeptides obtained after Ni+2-NTA
chromatography. The gel was stained with Coomassie Brilliant Blue R250. Various
amounts of the polypeptides were resolved by 15% SDS-PAGE.
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FIG. 3.3. SDS-PAGE analysis of IBV N and truncations thereof after gel-filtration
column chromatography. Various amounts of the polypeptides were resolved by 15%
SDS-PAGE. The gel was stained with Coomassie Brilliant Blue R250.
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The smaller proteins are probable truncations or degradation products. Gel permeation
chromatography of IBV N protein through a Superdex 200 matrix resolved four peaks of
protein eluting from the column (Table 3.2). Peak 1 corresponded to approximately a
443 kilodalton (kDa) complex eluting from the column at approximately 53.5 minutes as
compared to the molecular weight standards also separated by gel permeation
chromatography  (Tables 3.1 and 3.2 and Fig. 3.4 and Fig. 3.5). Peaks 2, 3 and 4
correspond to proteins much smaller than IBV N (less than 48 kDa) (Fig. 3.4 and Fig.
3.5). No peak corresponding to a 48 kDa molecular mass was obtained. The recombinant
N protein degrades over time and hence an abundant peak for the smaller products was
obtained (Fig. 3.4).
Electron microscopy (EM)
Since IBV N protein, present in peak 1 corresponded to a very high molecular
mass, it was of interest to determine if any structures are formed by IBV N protein. IBV
N protein was negatively stained with 2% uranyl acetate and observed by electron
microscopy. Aggregates and helical structures of lengths varying from 50 nm to 500 nm
and diameters from 6 to 10 nm were found in each of over ten preparations (Fig 3.6).
Each grid typically contained 6 to 10 such structures along with N protein aggregates
(Fig. 3.6). The size of the IBV virion itself is approximately 100-120 nm in diameter.
This suggests that certain other factors are important in compressing the helical
nucleocapsid to be encased into the virion or in limiting the growth of the helix.
It was of interest to determine if truncations of IBV N protein are capable of
forming these helical structures. Truncations of IBV N that corresponded to the amino
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Table 3.1.
Gel permeation chromatography: Elution profile of molecular weight standards (Tris
0.05 M pH7, 0.15 M NaCl) using superdex 200 gel matrix in an HR 16/60 column
Elution time in minutes Molecular weight (kDa)
48.6 669
53.8 443
60.8 200
66 150
74 66
88.3 29
Table 3.2.
Peaks after gel permeation chromatography of IBV recombinant N protein (Tris 0.05 M
pH7, 0.15 M NaCl) using superdex 200 gel matrix in an HR 16/60 column
Elution time in minutes  Peak number
53.5 1
92.5 2
116 3
122.54 4
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FIG. 3.4. Elution profile of Ni+2-NTA chromatography purified IBV N protein using a
Superdex-200 matrix in a 16/60 column. Peak1 corresponds to a molecular mass of
approximately 443 kDa as compared to the molecular-weight standards (each standard
peak is labeled with the corresponding molecular mass). Peaks 2, 3, and 4 are much
smaller than 48kD, the predicted molecular weight of monomeric IBV N protein.
1
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FIG. 3.5. SDS-PAGE analysis of IBV recombinant N protein obtained from fractions
eluted from the Superdex-200 (16/60) column. Lane 1, SDS-PAGE molecular weight
markers; lane 2, peak 1; lane 3, peak 2 and lane 4, peak 3. Small arrows represent the
major protein in the gel lane eluted from the column.
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terminal 91 amino acids (N91), amino terminal 171 amino acids (N171), amino acids
101-283 (M173), amino acids 203-409 (C207) and amino acids 268-407 (C140) (Fig
3.1) that had been expressed as histidine tagged fusion proteins  (Zhou et al., 1996) were
negatively stained with 2% uranyl acetate and examined by TEM. These truncations had
been used to determine the RNA binding region of the N protein. Except for N91 and
M173, all truncations bound the 3’-UTR of IBV as studied using the gel shift assay
(Zhou et al., 1996). The truncations formed a few protein aggregates similar to that seen
in figure 3.6, but no helical structures were observed in the preparations of the
truncations (Table 3.3) used for TEM studies.
N protein of several different viruses can form oligomeric structures that are
precursors to forming the nucleocapsid. The structures of these oligomers have been
determined using single particle image reconstruction of electron microscopic images
(Murphy  et al., 2003; Schoehn et al., 2001). It was of interest to determine if
recombinant IBV N forms such oligomers. Single particle image reconstruction involves
constructing a three-dimensional image of a macromolecule typically larger than 500
kDa from electron microscopic images of single particles of the macromolecule. Single
particle structure determination typically begins with preparation of a homogenous
sample that is placed on an electron microscope grid and prepared for imaging (Thuman-
Commike, 2001). TEM studies of the IBV recombinant N protein showed that it
consisted of protein aggregates in addition to helical structures, suggesting that it is not a
homogenous preparation.
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Table 3.3.
RNA binding (as determined using gel-shift assay) (Zhou et al., 1996) and ability to
form nucleocapsid-like structures by IBV N and its polypeptides
Amino acids RNA binding to 3’-UTR Ability to form
nucleocapsid-like structures
1-409 (N) + +
1-91 (N 91) - -
1-171 (N 171) + -
101-283 (M 173) - Not tested
203-409 (C 207) + -
268-407 (C140) + -
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FIG 3.6. Analysis by TEM of affinity-purified IBV recombinant N protein expressed in
E. coli. The arrow points to the helical nucleocapsid-like structure formed by IBV N
protein negatively stained with 2% uranyl acetate. The arrowhead points to small
aggregates and the double headed arrow points to large aggregates. The length varies
from 50 to 600 nm and the diameter varies from 6 to 10 nm. The bar below represents
100 nm.
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A homogenous preparation can be achieved by modifying the type and concentration of
ions. As a preliminary analysis, HEPES buffer with varying concentrations of
magnesium ions was used to determine the conditions to obtain a homogenous
preparation for single particle formation of recombinant IBV N protein. At 10 and 20
mM Mg+2 concentrations, large and small aggregates were visible (data not shown).
Above 40 mM Mg+2 concentrations, and up to 100 mM Mg+2 concentrations, a more
homogenous preparation without aggregates was obtained. No oligomers were formed
under these conditions. High concentrations of magnesium probably destabilize the
nucleocapsid-like structures. Other ions should be used to determine the conditions for
single particle formation of recombinant IBV N protein.
Thin section preparation of E.coli expressing the IBV N protein
Negatively stained thin sections of Sf9 cells expressing the rabies virus
nucleocapsid protein showed the presence of helical nucleocapsid-like structures (Pinto
et al., 1994). To determine if such structures are visible in E.coli preparations expressing
the IBV N protein, thin sections of induced and uninduced preparations of bacteria were
stained with 2% uranyl acetate and Reynold citrate and observed by TEM. No
nucleocapsid-like structures were observed within the thin sections of the induced
bacterial preparations (Fig. 3.7B). Fine detail was not clear within both uninduced and
induced bacterial preparations (Figures 3.7A and 3.7B) when studied at 40,000X or
80,000X magnification, probably due to dense packing of cell contents. At least five
grids of both induced and un-induced preparations of bacteria were studied using TEM.
Using bacterial lysates might be a better alternative than whole cells to determine the
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FIG 3.7. TEM images of thin sections of (A) uninduced E. coli and (B) induced E.coli
expressing IBV recombinant N protein using a JEOL 1200 EX transmission electron
microscope at an accelerating voltage of 80kV. The bar represents a scale of 100 nm.
A
B
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presence of these structures in E. coli.
Determination of RNA in IBV N protein preparations
Nucleocapsid proteins have a tendency to self assemble and form regular
structures in the presence of RNA or DNA (Pinto et al., 1994; Spehner et al., 1991;
Warnes et al., 1995). The carboxyl region (C140) of IBV N also forms oligomers as
observed by gel permeation chromatography through a BioGel-P60 column. Most of the
protein elutes in the void volume of the column indicating the presence of a large
complex (data not shown). IBV N is an RNA binding protein (Zhou et al., 1996). To
determine if RNA from E.coli was associated with the affinity purified N preparations,
the nucleic acid was in vivo labeled with 32P-orthophosphate during N protein induction.
The nucleic acid associated with Ni+2-NTA affinity purified N protein was isolated using
TRIZOL reagent.  RNA is present in the aqueous phase and the DNA and protein are
present in the phenol-chloroform phase. The nucleic acid isolated from the aqueous
phase was split in to three parts and two parts were treated with 10 µg RNase A and 2 U
DNase I respectively, to determine the nature of the nucleic acid associated with the N
protein. Denaturing agarose gel electrophoresis showed the presence of nucleic acid
associated with N protein from both uninduced and induced bacteria (Fig. 3.8). Higher
amounts of nucleic acids were found associated with samples from induced bacteria as
compared to samples from uninduced bacteria. Leaky expression of N protein in the
uninduced bacteria can account for the low levels of nucleic acid associated with the
preparation. For both uninduced and induced preparations, RNase A treatment degraded
the RNA completely, however DNase I treatment (Fig. 3.8) showed a marginal decrease
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FIG. 3.8. Analysis of presence of RNA in preparations of IBV recombinant N protein
purified by affinity chromatography. RNA isolated by Trizol extraction from induced E.
coli DH5α cells lacking any expression construct, from uninduced bacteria containing
the N-gene expression construct, and from bacteria containing the N-gene expression
construct induced with 2 mM IPTG.
3,000
1,500
10 µg RNase A
2 units DNase I
    –   +    –            –    +   –             –    +   –
    –   –    +            –    –   +             –    –   +
         DH5α             Uninduced         Induced
10,000
5,000
4,000
2,000
1,000
500
     200
92
in the intensity of the bands, which may have been due to a contamination of RNase A
or due to the presence of small amounts of DNA associated with the N protein.  Small
amounts of nucleic acid were isolated from the E. coli DH5α cells (Fig. 3.8). The
nucleic acid was either RNA or DNA as shown by absence of bands in the samples
treated with RNase A or DNase I respectively. The sizes of the RNA obtained from
uninduced and induced E. coli containing the N gene expression construct were close to
3000, between 1000-1500 and between 200-500 nucleotides (Fig. 3.8). The N gene
transcript is 1254 nucleotides in length. The 23S, 16S, and 5S ribosomal RNA (rRNA)
from E. coli K12 measure 2904, 1543, and 120 nucleotides respectively in length
(Blattner et al., 1997). The sizes of the RNA associated with the N protein are very close
to the sizes of the N gene transcript, 23S and 16S ribosomal RNA. Higher levels of
nucleic acid corresponding to 1000-1500 and 200-500 nucleotides (nt) in length were
found associated with the induced preparation as compared to the uninduced preparation.
IBV N has been shown to bind to its own transcript as well as to non-IBV RNA (Zhou et
al., 1996). It is possible that the nucleic acid bound to IBV N is the N gene transcript
(1254 nt) and/or E. coli 16S rRNA (1543 nt) and other E. coli RNA (200-500 nt). Hence,
it is possible that RNA is present in the helical-nucleocpasid-like structures observed in
the recombinant N protein preparations. RNase A-gold immunolabeling of the structures
followed by TEM can conclusively determine the presence of RNA in these structures.
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DISCUSSION
The IBV nucleocapsid protein binds viral RNA forming a helical nucleocapsid
that interacts with other structural proteins to assemble the complete virion (Davies et
al., 1981). Using electron microscopy, we showed that the IBV recombinant
nucleocapsid protein expressed in E.coli also forms helical nucleocapsid-like structures
devoid of other viral structural proteins. When individual, overlapping fragments of the
N protein were examined such helical structures were not obtained. This suggests that
formation of the helical structures depended on the full length N protein. RNA binding
studies have demonstrated that the amino and carboxyl regions of the N protein bind
RNA (Zhou et al.,  1996). Other experiments with C140 suggest that it aggregates and
hence may be important in N interacting with itself. These results once again are
consistent with the full length N protein being important in formation of the
nucleocapsid-like structure. Nucleocapsid proteins of several viruses are known to self-
assemble or in the presence of other viral proteins, to form nucleocapsid-like structures
(Errington and Emmerson, 1997; Fooks et al., 1993; Gross et al., 1997; Iseni et al.,
1998; Murphy et al., 2003).
Nucleocapsid assembly in measles virus, rabies virus, Newcastle disease virus,
human immunodeficiency virus (HIV) and respiratory syncytial virus (RSV) occurs
when expressed in Sf9 cells or in E.coli in the presence of non-viral RNA (Errington and
Emmerson, 1997; Fooks et al., 1993; Gross et al., 1997; Iseni et al., 1998; Murphy et al.,
2003).  However, it is not known if RNA is present in the nucleocapsid-like structures
formed by the IBV N proteins. RNA is associated with the N protein preparation as
94
confirmed by the sensitivity of the co-purifying radiolabeled nucleic acids isolated from
the N protein preparation to RNase A. Small amounts of DNA may also be present in the
preparation due to the sensitivity of the oligonucleotide to DNase I. The sizes of the
RNA vary from close to 3000, between 1000-1500 and between 200-500 nucleotides.
The IBV N protein binds RNA non-specifically as shown by gel shift assays (Zhou et
al., 1996).  Since varying lengths of nucleocapsid-like structures are formed, it is
possible that the N protein binds to either E. coli RNA or the N RNA transcript to form
these nucleocapsid-like structures. A northern blot assay using a probe to the N gene can
help identify if the N gene transcript is present in the recombinant N protein preparation.
What is the significance of formation of these structures in E.coli? Since the IBV N
protein is over expressed, the large amounts of N protein produced in E. coli interact
with each other, as well as with the RNA, to form these structures. It reflects the self-
assembling nature of the IBV N protein. What is the significance in the virus-infected
cell? MHV RNP complexes are found in the infected eukaryotic cell wherein the N
protein is found associated with genomic and subgenomic RNA (Narayanan et al.,
2003b). It is not known if the RNP complexes in the eukaryotic cell have a regular
structure. There are several possible explanations of events in the cell associated with the
formation of these structures: 1) Other viral or host proteins may prevent formation of
these structures so that free RNA is available for transcription and translation and the
RNP complexes do not form any regular structures. 2) These nucleocapsid-like
structures may be present even in the infected cell. The diameter of these complexes in
E. coli is varied suggesting that unwinding of the helix was possible, leading to exposure
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of the RNA and making it accessible by the transcription and translation machinery.
RNP complexes from virions of IBV, MHV3 and HCV 229E have been shown to consist
of tightly bound coils of 9 to 13 nm in diameter or of more loosely bound coils of 14 to
16 nm in diameter (Macnaughton et al., 1978; Davies et al., 1981). This suggests that the
RNP structure can unwind when released from the virion. 3) The IBV N protein
concentrations might reach a certain threshold concentration after which viral assembly
is initiated, leading to the formation of helical nucleocapsid-like structures. 4) Other
modifications associated with eukaryotic systems might prevent the N protein from
forming these nucleocapsid-like structures in the infected cell prior to nucleocapsid
assembly.
In respiratory syncytial virus, amino acids 1 to 92 are sufficient for forming the
nucleocapsid-like structure (Murphy et al., 2003). N-N interactions are important in the
nucleocapsid of bluetongue virus, hantavirus, hepatitis C virus and porcine reproductive
and respiratory syndrome virus (Alfadhli et al., 2001; Kunkel et al., 2001; Salanueva et
al., 1999; Wootton and Yoo, 2003). N91, N171, C207 and C140, truncations of the IBV
N protein (Fig. 3.1) bind an RNA transcript containing the N gene and the 3’
untranslated region (UTR) of IBV. M173 does not bind this transcript (Zhou et al.,
1996). Binding may be mediated by the 3’-UTR and/or regions of the N gene. The N
protein also shows some non-specific binding to RNA (Zhou et al., 1996). It is likely
that if RNA is present in the helical structures, although some fragments of N are
capable of binding RNA, the protein-protein interaction domain(s) may be lacking,
resulting in no formation of helical-nucleocapsid-like structures. Even if formation of
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these structures does not require RNA, the protein fragments are probably incapable of
forming these structures due to absence of N-N interaction.
Nucleocapsid independent-assembly of virus like particles is possible by co-
expressing the membrane and envelope proteins (Vennema et al., 1996). The RNA that
is packaged by the VLPs formed as a result of co-expressing the M and E proteins is
much smaller than the genome. Extended RNP-like structures from the IBV virion have
been shown to be as long as 6.7 µm in length (Davies et al., 1981). Packaging of the
26.7 kb genome (approximately 9µm in length) into the IBV virion requires that the
RNA be compacted since the virion itself is 100-120nm in diameter (Davies and
Macnaughton, 1979). The volume of the spherical IBV virion 100 nm in diameter is
5.233 x 105 nm3.  The volume of a rod-shaped RNP-like structure from IBV 6.7 µm in
length and 10 nm in diameter is 5.259 x 105 nm3. Although the volume of the spherical
virion and the rod-like nucleocapsid-like structure from the virion is fairly close, the
radius of the RNP-like structure should be approximately 5 nm so that it can be
packaged in to the virion. Hence, other factors that can compress the helical
nucleocapsid to accommodate it into a 100-120 nm diameter particle are also important
in forming the virion. There are two possibilities: 1) an alternative morphology of N in
the presence of other proteins, 2) the helical rod is folded/compacted by other proteins. It
is not clear as to what nucleation event leads to the formation of the nucleocapsid and to
packaging of the genome. We show here that extended helical-nucleocapsid-like
structures are formed when the IBV N protein is expressed in E. coli as a recombinant
histidine-tagged fusion protein. Therefore, combinations of M-M, M-N, M-RNA, and N-
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RNA interactions are all likely to be important in specifically packaging the viral
genome. The recombinant N protein used in this study is not phosphorylated. Hence,
phosphorylation might not be necessary for the formation of an elongated nucleocapsid-
like structure as observed with bacterially expressed recombinant IBV N.
Phosphorylation however might be important in specificity of binding viral RNA for
nucleocapsid formation or in some other aspect of virus assembly.
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CHAPTER IV
INTERACTIONS OF RECOMBINANT IBV NUCLEOCAPSID PROTEIN AND
THE 3’-UNTRANSLATED REGION OF THE IBV VIRAL RNA
INTRODUCTION
The IBV nucleocapsid (N) protein is 409 amino acids long (approximately 48
kDa). MHV N is the only phosphorylated protein in the virus. It is present in the cytosol
of infected cells, and also binds small leader RNA that are a part of transcription
complexes found associated with cellular membranes (Baric et al., 1988). Although the
IBV N protein has many arginine and lysine residues, it lacks any domain characteristic
of RNA binding proteins (Williams, 1993). This has also been confirmed using the N
protein is multifunctional and has been implicated in playing a role in genome
replication, transcription of subgenomic RNA, translation and in formation of the
nucleocapsid (Masters et al., 1990; Masters and Sturman, 1990; Tahara et al., 1998).
Translation of the N protein is required for optimal replication of BCoV DI RNA and in
initiating infection with coronavirus molecular clones (Chang and Brian, 1996; Krishnan
et al., 1996). Co-transfection of transcripts of the N gene open reading frame and the in
vitro assembled virus genome sequence is required for the production of coronavirus in
cell culture using reverse genetics approaches (Casais et al., 2003; Yount et al., 2000;
Yount et al., 2002). The N protein has been shown to bind to the 5’-UTR, 3’-UTR, the
leader sequence, and also the intergenic sequence (Nelson et al., 2000; Zhou and
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Collisson, 2000; Zhou et al., 1996) of the MHV and IBV viral genomes. Anti-
nucleocapsid protein monoclonal antibodies precipitate both full length and subgenomic
mRNAs, as well as replicative intermediate RNA (Stohlman et al., 1988). Both MHV
and BCV N bind to the 3’ end of the N ORF and also to a sequence in the 1b region that
encodes the packaging signal sequence. N protein binds viral sequences with a greater
affinity than non-viral sequences (Cologna and Hogue, 2000; Zhou et al.).
A three-domain structure for the IBV N protein has been suggested based on
sequence comparisons of the N protein of the various IBV strains: the amino-terminal
region, the middle region and the carboxy-terminal region (Williams et al., 1992). The
IBV whole N protein, the amino-terminal and the carboxy-terminal regions of the N
protein bind the 3’-UTR of the viral genome (Zhou and Collisson, 2000; Zhou et al.,
1996). The middle region does not bind the 3’-UTR but has been shown to bind the 5’-
UTR of the viral genome (Zhou, 1997). The N protein binds the different regions of the
3’-UTR with varying affinities. Certain U-rich regions are bound with greater affinity
than other regions (Collisson et al., 2001). These interactions are likely to be important
in RNA-transcription, replication and translation.
Most techniques examining RNA-protein interactions, such as filter binding
assays, electrophoretic mobility shift assays, and structural studies, describe binding
under equilibrium conditions. Although these methods provide information about the
affinity of the interactions, they provide little or no insight into the kinetic parameters
underlying complex formation. RNA-protein interactions are dynamic, and the rates of
binding and release can affect many biological processes (Myszka, 2000; Myszka and
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Rich, 2000). A more comprehensive approach would be to examine RNA-protein
interactions under equilibrium conditions and as a dynamic process. BIAcore, a
technology based on   surface plasmon resonance (SPR), provides both equilibrium and
kinetic information about intermolecular interactions (Myszka, 1997; Myszka, 2000).
Surface plasmon resonance (SPR)
SPR is an optical phenomenon that arises when incident light is reflected from a
thin metal film (gold in BIAcore instruments) between two layers. Light projected
through a prism will be reflected from the film at all but one angle, where light is
absorbed and converted into an evanescent wave that propagates into the medium on the
nonilluminated side of the metal film. Changes in refractive index on the non-
illuminated side within 300 nm of the gold surface lead to a change in the identity of the
absorbed angle (Fig. 4.1 a). This system allows intermolecular interactions to be
visualized in real time: One of the molecules, the ligand, such as biotinylated RNA, is
coated onto the surface matrix, and a second molecule, the analyte, IBV N protein, is
injected into the flowing buffer. As the N protein reaches the RNA surface, binding
occurs, leading to a change in refractive index near the gold surface, which results in a
change in the angle at which light is absorbed (Fig. 4.1 a and Fig 4.1 b). This change,
closely related to the change in mass near the gold surface due to the protein binding, is
recorded by an optical unit and sent to a computer which displays a trace of binding vs.
time called a “sensorgram”. The rate at which change occurs upon injection of analyte
provides readout for the association rate of the molecules (Fig. 4.1 c). After the injected
protein has passed over the surface, it is followed by buffer flow and the dissociation can
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FIG. 4.1. BIAcore system. The BIAcore makes use of the phenomenon of surface
plasmon resonance. The instrument has a light source and an optical detection unit that
are on one side of the thin gold film (sensor chip). As plane polarized light from the light
source shines on the sensor chip, it is reflected at all angles but one, at which it will be
absorbed into the gold surface in the form of an evanescent wave (angle I). The identity
of the absorbed angle depends on the refractive index of the material close to the
nonilluminated side of the gold surface, where the binding reaction takes place. RNA is
immobilized on the nonilluminated side of the sensor chip. As a protein sample is
injected into the flow cell and binds to the RNA, it causes a change in the refractive
index. Such a change will result in a shift in the absorbed angle, to angle II. The change
in angle is recorded by the detector and is displayed in the form of a sensorgram.
(Adapted from Katsamba et al., 2002).
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be observed as the protein gradually dissociates from the RNA, and the absorbed angle
returns to the preinjection value. Subsequently, a new injection can be performed. The
time it takes for the angle to return to baseline depends on the off-rate of the interaction.
Here, SPR is used to study the binding of IBV N protein to the terminal 40 nucleotides
of the 3’UTR.
MATERIALS AND METHODS
Expression and purification of the IBV recombinant nucleocapsid protein
The N gene and several truncations of the N gene were cloned into pQE8 vector
and expressed as a histidine-tagged protein in E. coli M15 cells (Zhou et al., 1996). Fifty
ml of an overnight culture of bacteria grown in SOC medium containing 50 µg/ml
ampicillin and 25 µg/ml kanamycin were inoculated into 450 ml SOC medium
containing the same antibiotics. The bacteria were cultured at 37°C on a shaker at 200
rpm for three hours. Protein expression was induced with IPTG at a final concentration
of 2 mM. The bacteria were cultured for another five hours at 37°C on a shaker at 200
rpm and harvested by centrifuging at 3000 g. The pellet was suspended in non-
denaturing buffer (0.05 M Tris, pH 8, 0.3 M NaCl, 0.01 M imidazole). Lysozyme was
added at a final concentration of 0.1 mg/ml and the sample was incubated on ice for 30
minutes. The sample was lysed on ice by sonication at a 100 W power output, 10 s
pulses, six times with 10 s intervals. The sample was centrifuged at 5000 rpm at 4°C for
10 minutes, in a JA 21 rotor. The supernatant was collected and 1 ml of a 50% Ni+2-
NTA resin (Qiagen, Chatsworth, CA) was added to every 10 ml of cell lysate. The mix
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was incubated on a shaker at 4°C for one hour. The resin was collected by centrifuging
at 1800g, in a Joun CR412 centrifuge at 4°C for 1 minute and washed three times with
10 ml of wash buffer (0.05 M Tris, pH 8, 0.3 M NaCl, 0.02 M imidazole). The protein
was eluted from the resin with 1 ml of elution buffer (0.05 M Tris, pH 8, 0.3 M NaCl,
0.25 M imidazole). Approximately 3 mg of N protein were obtained per 500 ml of
bacterial culture. Polypeptides equal to, or greater than, 274 amino acids in length were
further purified by gel permeation chromatography using a Sephadex G200 (Sigma, St.
Louis, MO) or Superdex 200 (Amersham Biosciences, Piscataway, NJ) while peptides
equal to, or smaller than, 207 amino acids were purified with Bio-gel P60 (Bio-Rad,
Richmond, CA). Five ml of each sample were loaded onto the column before washing
with Tris buffer (Tris 0.05 M pH 8, 0.3 M NaCl). Fractions were monitored with the
Bio-Rad protein assay reagent (Bio-Rad, Richmond, CA), and the fractions containing
protein, were analyzed by 15% polyacrylamide gel electrophoresis (Sambrook et al.,
1989). Protein used for electron microscopy was dialyzed in HEPES buffer (25 mM
HEPES, 25 mM EDTA, 150 mM NaCl, 5 mM DTT and 5% glycerol).
Western blot assays were used to determine the viral specificity of the
recombinant polypeptides (Sambrook et al., 1989). Briefly, varying amounts of the
various proteins were separated by 15% polyacrylamide gel electrophoresis and blotted
onto nitrocellulose membranes. After blocking the membranes with 5% skim milk in
Tris buffered saline (TBS, pH 7), the membranes were reacted sequentially with chicken
anti-IBV Gray antibody and alkaline phosphatase conjugated goat anti-chicken IgG
(KPL, Gaithersburg, Maryland).
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 Synthesis of RNA
Minus and plus strand DNA oligonucleotides corresponding to the RNA
sequences used in this study were synthesized with the T7 promoter at the 5’ end of the
positive strand. Double strand oligonucleotides were obtained by annealing the genomic
sense and anti-genomic sense DNAs. The RNA fragments were transcribed from these
synthetic oligonucleotides with 2 µg DNA template, 40 units T7 RNA polymerase,
rATP, rCTP and rGTP at a final concentration of 1 mM and 100 µM of rUTP
(Invitrogen, Carlsbad, CA), 50 µCi of αP32 labeled rUTP (Perkin Elmer, Wellesley,
MA), 80 units of RNasin (Promega, Madison, WI), 5X transcription buffer and 1 mM
DTT (final concentration). The reaction was incubated at 37°C for 2 hours and
terminated with the addition of 1000 units of DNase I (Roche Biochemicals,
Indianapolis, Indiana) and incubating at 37°C for 15 minutes. After extracting the RNA
probe with phenol chloroform, and cleaning with a spin column (Eppendorf, Boulder,
CO) to remove unincorporated nucleotides, the RNA was quantified by gel
electrophoresis by comparing with yeast t-RNA. This probe was heated to 70°C for 10
minutes and flash frozen to -20°C to remove any secondary structures. The 40 mer, 15
mer poly U and 40 mer RNA oligonucleotide corresponding to the terminal 40
nucleotides of the 3’-UTR of IBV were synthesized by Dr. Paul Gershon (Institute of
Bioscience and Technology, Houston, TX) using phosphoramidite chemistry on a model
392 DNA/RNA synthesizer (Applied Biosystems, Foster City, CA.)
Alkaline phosphatase treatment and end labeling of RNA
10 pmoles of RNA were treated with 0.05 units of calf intestinal alkaline
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phosphatase (CIAP) in CIAP buffer in a 50 µl reaction volume at 37°C for 30 minutes.
Another 0.05 units of CIAP were added and the reaction was incubated under the same
conditions for another 30 minutes. The reaction was terminated with CIAP stop buffer
(10 mM Tris-HCl, pH 7.5; 1 mM EDTA, pH 7.5; 200 mM NaCl and 0.5% SDS),
followed by phenol chloroform extraction of RNA and precipitation with 0.5 volumes of
7.5 M ammonium acetate and 2 volumes of ethanol at room temperature. At the end of
two hours, the RNA precipitate was recovered by centrifugation at 12,000 g, for 20
minutes. This RNA was used for 5’ end labeling. End labeling was carried out with 150
µCi of 32P γ-ATP and 20 units of T4 polynucleotide kinase in appropriate buffer in a 30
µl reaction volume. The reaction was incubated at 37°C for one hour and stopped with 1
µl of 0.5 M EDTA. The RNA was extracted by phenol-chloroform and purified by
precipitation as mentioned above.
Gel shift assays
Protein-RNA interactions were analyzed by a modified gel-shift assay (Chodosh,
1992). Varying concentrations of RNA and 65.54 picomoles (3 µg) of the nucleocapsid
protein were co-incubated for 20 minutes at room temperature (25°C) in 10 µl of gel
shift assay buffer {25 mM HEPES, 5 mM EDTA, 150 mM NaCl, 5 mM DTT, 5%
glycerol and 20 units rRNAsin (Invitrogen, Carslbad, CA)}. Following the addition of 1
µl 10X RNA loading buffer, the reaction mixtures were loaded onto either 6%
polyacrylamide gels or 1% metaphor agarose gels and electrophoresed at 100V in 1X
Tris-borate-EDTA (Sambrook et al., 1989). Gels were dried and then subject to
autoradiography.
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Competitive gel shift assays
Competition assays were performed using 65.54 picomoles of nucleocapsid
protein and different concentrations of the radiolabeled RNA and unlabeled heterologous
competitor RNA in 10 µl reaction volume. Briefly, the probe, protein and cold
competitor RNA were mixed together in gel shift assay buffer for 20 minutes at room
temperature. After adding gel-loading dye, the complexes, if any, were resolved by
agarose gel electrophoresis. The gel was dried and then subject to autoradiography.
Surface plasmon resosnance (SPR)-BIAcore   
The CM5 sensor chip was activated using N-hydroxisuccinimide (NHS) and 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) (BIAcore) at a
flow rate of 5 µl/min. 80 µg/ml of streptavidin in 25 mM sodium acetate pH5 (total
volume 100 µl) was injected at a flow rate of 5 µl/min in running buffer (20 mM
HEPES, pH 7, 100 mM NaCl, 0.05% Tween 20) until 2800 RU of streptavidin was
immobilized on the sensor chip. This was followed by deactivation of unreacted NHS-
esters using 35 µl 1 M ethanolamine hydrochloride adjusted to pH 8.5 with NaOH. This
was followed by an injection of biotinylated RNA (70 µl) in running buffer till a surface
coating of 750 RU was reached. Varying concentrations of protein in different buffers
were injected at a flow rate of 5 µl/min to determine the optimum conditions for binding.
The bound protein was dissociated by injecting running buffer at a flow rate of 100
µl/min. This was followed by regeneration of the chip by injecting 0.5 M NaCl in
running buffer at a flow rate of 40 µl/min. The regenerated CM5 chip could be reused
for studying binding for at least ten reactions or till the time the immobilized RNA
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remained intact. Buffer A (20 mM HEPES buffer, pH7, 0.05% Tween 20); buffer B (20
mM HEPES, pH 7, 150 mM NaCl, 0.05% Tween 20, 25 mM EDTA, 5 mM DTT).
RESULTS
Purification of IBV recombinant nucleocapsid (N) protein and the amino terminal
171 amino acids of the N protein
Ni+2-NTA affinity purified IBV N and N171 proteins were resolved by
denaturing polyacrylamide gel electrophoresis (SDS-PAGE). IBV N protein is
approximately 48 kilodalton (kDa) and N171 is approximately 20 kDa in molecular
mass. The identity of the proteins was confirmed using chicken anti-IBV Gray antibody
using a Western blot assay (Fig.4.2). These purified proteins were used for the gel shift
and surface plasmon resonance assays. Recombinant IBV N protein tends to degrade
probably due to small amounts of bacterial proteases co-purifying with the protein, in
which case additional procedures need to be used to obtain pure protein. However, for
this experiment the recombinant proteins appeared pure after a single purification step.
Surface plasmon resonance (SPR)
 N171 (the amino 171 amino acid residues of the IBV nucleocapsid protein) was
used for the assay, because N171 was of greater purity than IBV N. Binding of N171 to
the terminal 155 nucleotides of the 3’-UTR has been demonstrated by Zhou et al.
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FIG. 4.2. Western blot analysis of the recombinant IBV N protein and the recombinant
amino terminal 171 amino acids (N171) of the IBV N protein purified by Ni+2-NTA
chromatography.
N      N171
48 kD
20 kD
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FIG. 4.3. Effect of NaCl concentration on binding of N171 and 3’-UTR 40 mer RNA of
IBV using surface plasmon resonance. Binding was carried out with 3.75 µM N171 in
running buffer containing (A) 25 mM NaCl, (B) 50 mM NaCl, (C) 100 mM NaCl, (D)
200 mM NaCl and (E) 250 mM NaCl.
A B
C D
E
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(1996). Biotinylated sequences 40 to 50 nucleotides in length were easier to synthesize
than the 155 nucleotides of the 3’-UTR used by Zhou et al. (1996) for the gel shift assay.
Hence, the terminal 40 nucleotides of the 3’-UTR were used to standardize conditions
for binding of N171 to viral RNA using SPR. The signal from association of N171 with
RNA (in resonance units, RU) was calculated after subtraction from the sensorgram of
the baseline due to the immobilization of RNA alone. The maximum level of binding
was obtained at 50 mM NaCl concentration with running buffer A and 3.75 µM of the
protein (Fig. 4.3, Table 4.1). However, running buffer B has a composition closer to that
of the buffer used in our gel shift assays. A higher relative resonance response was
obtained using 3.75 µM of N171 and running buffer B (Fig. 4.4, Table 4.2). Binding of
1.875 µM, 3.75 µM, 5.625 µM, 7.5 µM, 9 µM, 11.25 µM and 15 µM of N171 to the 3’-
UTR terminal 40 nucleotides were evaluated. The maximum binding increases until a
protein concentration of 5.625 µM, and the response drops down for the next two
concentrations of 7.5 µM and 9 µM, and again increases for the 11.25 µM and 15 µM
protein concentrations (Fig. 4.4, Table 4.2). All responses to study the effect of protein
concentrations on the binding of N171 to the terminal 40 nucleotides were carried out
using the same flow cell coated with RNA. RNA degrades over time and hence could
affect the relative response obtained due to protein binding. Regeneration of the surface
to remove bound protein is important as well. If the binding surface does not regenerate
completely, a lower response would be obtained on the next cycle. Error in diluting the
proteins could also lead to erroneous responses. We did not serially dilute the protein
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Table 4.1.
Effect of NaCl concentration on binding of N171 to the terminal 40 nucleotides of the
3’-UTR of IBV
mM NaCl
concentration
Relative maximum RU
during association
25 3145.2
50              10949.7
100                5961.1
200                6922.0
250                7005.4
Table 4.2.
Effect of protein concentration on binding of N171 to the terminal 40 nucleotides of the
3’-UTR of IBV
µM Protein
concentration
Relative maximum RU
during association
1.875 567.2
3.75               1148.7
5.625               1469.0
7.5               1048.7
9                 951.4
11.25               1792.1
15               1960.0
112
FIG. 4.4. Effect of protein concentration on binding of N171 and 3’-UTR 40 mer RNA
of IBV in running buffer using surface plasmon resonance. Binding of (A) 1.875 µM (B)
3.75 µM, (C) 5.625 µM, (D) 7.5 µM, (E) 9 µM, (F) 11.25 µM and (G) 15 µM N171 to
3’-UTR 40 mer RNA.
A B
C
D
E
F G
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and hence that could also lead to the observed effect. The experiment was done once and
hence we cannot comment on the reproducibility of the relative response obtained.
An attempt was made at determining the rate constants and the equilibrium
constant. The data were fit (p values < 0.05) to the simple model A + B ↔ AB, 1:1
stoichiometry. The apparent dissociation rate constant  (kdiss) was 5.91 x 10
-5 s-1 and the
apparent association rate constant (kass) was 100 M
-1s-1. The apparent association
equilibrium constant (kA = kass/kdiss) was 1.6 x 10
6 M-1. The analysis should be repeated
to confirm the results.
Gel shift assays
IBV N binds sequences containing an elevated U content (Collisson et al., 2001).
To determine the ability of IBV N to bind poly U sequences, gel shift assays were
carried out with IBV N and a 15- and 40-nucleotide poly U sequence. IBV N protein
bound to both a 15-mer and 40-mer poly U RNA as observed by a shift in the RNA band
in presence of the N protein. This binding was specific as it occurred in the presence of a
large excess of yeast tRNA. To determine the relative ability of IBV N protein to bind
U-rich sequences, competitive gel-shift assays were performed with U-rich regions of
the IBV genome and the (U)40 mer.
IBV N protein binds G2 RNA (N gene + IBV 3’UTR) and CD RNA (terminal
155 nucleotides of the 3’-UTR) (Zhou et al, 1996). The 3’-UTR region of the IBV
genome is U-rich. Competitive gel shift assays were performed with poly U as
competitor and G2 RNA probe and CD RNA probes. All these RNA are predicted to
form secondary structures when analyzed by the m-fold program (Zhou, 1999).
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FIG. 4.5. Gel shift assays using (A) 1 ng poly U15 and (B) 1 ng poly U40 as probe and 3
µg N protein. Lane 1 represents binding of N protein in presence of yeast-t-RNA; lane 2,
free probe and lane 3 shows binding of nonspecific protein BSA to probe. Competitive
gel shift assays for cold poly U40 as competitor and C) G2 RNA and D) CD RNA
probes. Lanes 1 through 5, have labeled probe with 3 µg N protein and two-fold
dilutions of competitor starting with 150 ng of poly U40 up to 9.375 ng in lane 5; lane 6 is
free probe and lane 7 is N protein and probe without the competitor.
G2 RNA probe
  1  2  3  4  5  6   7
C
CD RNA probe
  1  2  3  4  5  6 7
D
Poly U-40 probe
  1    2     3
B
Poly U-15 probe
  1     2     3
A
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Competitive gel shift assays using G2 RNA as probe and (U)40 mer as competitor
showed that even a 106-fold excess of cold competitor could not compete out the
binding. This is possibly due to the large size of the G2 RNA. Binding of N171 to
0.0189 pmoles of CD RNA was not competed out by approximately 106-fold excess of
cold competitor poly U RNA (Fig. 4.5).
DISCUSSION
The genome of IBV is U rich with an average of 32.7% of uridine. The 3’-UTR
and 5’-UTR contain 37% and 29% uridine respectively. The 5’ and 3’-UTR’s have been
shown to be important in replication of DI’s and in subgenomic RNA synthesis. Since
the N protein binds the 3’-UTR and 5’UTR, these effects may be influenced by the
presence of uridine. Sequence specificity and secondary structure are also likely to be
important in binding. Our gel-shift assays are designed to determine the sequence
specificity of binding, and not secondary structure of RNA for protein binding as there
are no ions (such as Mg+2 or Zn+2) that help RNA folding. Since the N protein also binds
the (U)15 RNA probe, it can be said that such short lengths are not a constraint for
binding of the N protein to form an RNA-protein complex.
The competitive gel shift assay is an effective method to determine the relative
binding affinities of the N protein for the various sequences. The large difference in size
and putative secondary structure of the G2 (1800 nucleotides) and CD (155 nucleotides)
RNA probes may have prevented the competition by cold (U)40 RNA. The secondary
structure may facilitate greater binding of the N protein and hence the inability to
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compete out binding by (U)40. Smaller RNA sequences with varying U percentages
would have been very useful to determine the sequence context of uridine for N protein
binding.
A preliminary analysis using SPR to study the binding of N171 to the terminal 40
nucleotides of the IBV 3’-UTR was carried out. Since a higher resonance response was
obtained in running buffer B (resembled the gel shift assay buffer) than running buffer
A, the running buffer B was more appropriate than running buffer A for N binding RNA
using the BIAcore. The apparent association and dissociation rate constants were
calculated using the BIAcore 2000 BIAevaluation software. Employing gel shift assays,
Zhou et al. (1996) have characterized the RNA binding domain of the IBV N protein
using polypeptide truncations of the IBV N protein and the 3’-UTR RNA. Our results
show that SPR can be used in future to further accurately determine the kinetics of
binding of the N protein truncations to the 3’-UTR 50 nucleotides. More detailed
analysis of the ratio of RNA and protein in the complex was not possible because the
original data files were misplaced. Further experiments could not be conducted owing to
limited time and financial resources. This technique, however, can be used to model
RNA-protein interactions.
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CHAPTER V
A RAPID ELISA TECHNIQUE USING THE BIOWAVE MICROWAVE
Reticuloendothelioses virus (REV) and feline immunodeficiency virus (FIV) are
retroviruses that infect prairie chickens and cats respectively and infectious bronchitis
virus (IBV) is a positive stranded RNA virus that infects chickens. These viruses are
pathogens of veterinary interest. Enzyme linked immunosorbent assay (ELISA) is a
commonly used technique for detection of virus or viral specific antibodies, however
traditional ELISAs can take up to two days for completion versus expensive pre-
prepared kits that can yield results within three hours (IDEXX). Traditional ELISAs for
the detection of antibody to infectious bronchitis virus (IBV) in chicken serum take at
least two days for completion (Ndifuna et al., 1998). ELISAs to detect REV and FIV in
cell culture that are routinely performed in our laboratory take 8 hours for completion.
We have now developed a rapid ELISA technique using a special type of microwave
called the PELCO BIOWAVE (Ted Pella Inc., Redding, CA) that can be completed in
less than two hours.
The BIOWAVE microwave (Ted Pella Inc.) has the following unique features.
(1) It can maintain a constant, controlled, monitored, temperature from 4°C to 40°C. (2)
The wattage in the system can be controlled and it provides continuous microwave
energy settings of up to 450 watts. (3) A patented temperature controlled processing
surface (PELCO ColdSpot ) that eliminates hotspots and ensures uniform heating of the
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substance placed within the BIOWAVE. The BIOWAVE has been used for
immunochemical techniques such as fluorescent in situ hybridization (FISH) and
immunohistochemistry and for tissue embedding for thin section preparation for electron
microscopy (Ted Pella Inc., Redding, CA).
We used the PELCO BIOWAVE for the first time to detect REV and FIV in cell
culture supernatants and to detect IBV antibody in chicken serum. The BIOWAVE is
used to decrease the turn around time for completing an ELISA.
MATERIALS AND METHODS
Preparation of recombinant IBV nucleocapsid protein and REV gag protein
The N gene was cloned into pQE8 expression vector (Qiagen, Chatsworth, CA)
and expressed as a histidine-tagged protein in E. coli M15 cells (Zhou et al.,  1996). The
fusion protein was purified through a Ni+2-NTA column as described by Zhou et al.
(1996) and further purified by gel filtration through a Sephadex G200 column. The REV
gag protein was cloned in a pet Blue vector (Novagen, San Diego, CA) as a histidine-
tagged fusion protein and expressed and purified using the procedure described in the
Qiagen manual (Qiagen, Chatsworth, CA).
BIOWAVE
Either completing or breaking the circuit can regulate power output in the
BIOWAVE. Completing a circuit allows current to flow through the BIOWAVE thus
heating the interior (the on cycle) and breaking the circuit stops current flow (the off
cycle) thereby stopping heating within the BIOWAVE. The off cycle essentially allows
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the sample being heated to cool down and not be subject to continuous heat energy. The
on and off cycles can be programmed for various periods of time. Thus, any heating
program can consist of alternate cycles of heating and cooling for up to a total of 6
cycles. The BIOWAVE microwave was set at 250 W and 30°C. Cycle A was
programmed for a 2 min on cycle, 2 min off cycle and a 2 min on cycle for a total of 6
minutes. Cycle B was programmed for a 1 min on cycle at 250 W. Cycle A was used for
coating antigen (N protein, gag protein or supernatant containing virus), antibody,
streptavidin-horse raddish peroxidase conjugate (HRPO) or for the blocking step and
cycle B was used for the washing steps. All steps were carried out at 30°C.
IBV ELISA
The traditional ELISA protocol was performed using the method described by
Ndifuna et al. (1998). 96-well microtiter ELISA plates (Sumitomo Bakelite Co. Ltd.)
were coated with 50 µg/100 µl per well IBV recombinant N protein, diluted in
bicarbonate/carbonate buffer (Ndifuna et al., 1998). The plates were then blocked with
blocking-solution [5% w/v non-fat dry milk, 0.2% Tween 20, 0.02% sodium azide in
Tris buffered saline (TBS)]. After one wash with TBS-Tween 20 (0.2%) (TBT-T), 100
µl per well of chicken serum (containing anti-IBV Gray antibody) diluted in blocking
solution were added to each well. After washing the plates with TBS-T, 100 µl of a
1:1000 dilution of alkaline phosphatase conjugated goat anti-chicken antibody (KPL,
Gaithersburg, Maryland) in blocking buffer were added to the ELISA. After washing
with TBS-T, 5-bromo-4-choloro-3-indolyl phosphate (BCIP) and nitroblue tetrazolium
(NBT) one component substrate (KPL, Gaithersburg, Maryland) was added to the wells.
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The reaction was stopped after 20 minutes with 5% EDTA stop solution (KPL) and the
optical density (O.D.) measured at 405 nanometers (nm).
REV and FIV ELISA
Immulon 2HB strips (Thermolab systems, Franklin, MA) were used for the FIV
and REV ELISAs. ELISA strips were coated with rabbit anti REV gag polyclonal
antibody at a concentration of 20 µg/ml or with 50 µl mouse monoclonal anti FIV gag
antibody at a concentration of 20 µg/ml. The plates were then blocked with 300 µl 3%
BSA in phosphate buffered saline (PBS) pH 7.4 following which the plates were washed
once with PBS containing 0.05% Tween 20 (PBS-T). 20 µl Triton-X 100 per well and
200 µl of various dilutions of REV made in complete Dulbecco’s minimal essential
medium (DMEM) containing 2% fetal bovine serum (FBS) were then added to the wells.
Two fold dilutions of REV gag protein starting with 500 ng up to 1.5 ng were used as
standards. For the FIV ELISA, 10 µl Triton-X 100 per well and 100 µl of various
dilutions of FIV made in complete DMEM containing 10% FBS were added to the wells.
After washing the wells with PBS-T, for the REV ELISA, 100 µl rabbit anti-gag
biotinylated IgG (2 µg/ml) diluted in PBS containing 3% FBS were added to the wells
and for the FIV ELISA, 100 µl anti-mouse-biotinylated IgG (2 µg/ml) diluted in PBS
containing 3% fetal bovine serum (FBS) were added to the plates. The wells were then
washed with PBS-T and 100 µl of a 1:1000 dilution of streptavidin-conjugated-HRPO
diluted in PBS containing 3% FBS were added to the plates for both ELISAs followed
by a wash with PBS-T. Tetramethylbenzidine (KPL, Gaithersburg, Maryland) was used
as substrate for HRPO. The reaction was terminated with stop solution (KPL,
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Table 5.1.
Comparison of the traditional and the biowave ELISA protocols for REV and FIV
detection in cell culture supernatant
Traditional Biowave
Antibody R.T. for two hours 6 min cycle A
Blocking Overnight at 4°C 6 min cycle A
Wash Twice at R.T. 1 min cycle B
Antigen Two hours at R.T. 6 min cycle A
Wash Four times 1 min cycle B
Biotinylated antibody 30 minutes at R.T. 6 min cycle A
Wash Thrice 1 min cycle B
Sterptavidin-HRPO
conjugate
30 minutes 6 min cycle A
Wash Five times 1 min cycle B
Substrate 20 min at R.T. 20 min at R.T.
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Gaithersburg, Maryland) after 20 minutes. The O.D. was measured at 405 nm.
Comparisons of the traditional and BIOWAVE protocols are shown in Table 5.1.
The IBV, FIV and REV ELISAs were also done by using the timings of the
Biowave protocol for the various steps, though carried out at room temperature (R.T.)
(25 °C) or at 30°C.
RESULTS
IBV ELISA
ELISA was used to determine the presence of anti-IBV antibody in chicken
serum by four methods. Method 1 used the protocol of the traditional method (traditional
ELISA, slow, R.T.), method 2 (biowave ELISA, fast, 30 ºC) used the BIOWAVE for the
biowave protocol outlined in figure 5.1, method 3 (traditional ELISA, fast, 30 ºC) used
the biowave protocol timings though the ELISA was carried out  at 30°C and method 4
(biowave ELISA, fast, R.T.) used the biowave protocol timings and the ELISA was
carried out at R.T. In order to determine the effect of temperature on the ELISAs in the
absence of microwave energy, the ELISAs were also carried out with the biowave
protocol timings at 25°C and 30°C. The traditional ELISA method is carried out at 25°C
and the biowave ELISA was carried out at 30°C. With an increase in antibody dilution,
there was a decrease in the O.D. value for both the traditional and biowave ELISA
protocols tested. Results for the ELISA for the first three dilutions using method 3 gave
lower values as compared to the ELISA results obtained using method 1 and 2,
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FIG 5.1. Comparison of the traditional and the biowave protocols for IBV ELISA to
detect anti-IBV antibody in chicken serum using IBV recombinant nucleocapsid protein
as antigen. Values are an average of triplicates. The standard errors are 0.06 or less than
0.06.
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following which, the O.D. value dropped to zero. Results for the ELISA using method 4
with anti-IBV Gray antibody and negative serum as a control gave a low background
O.D. value. The value was considerably lower than the values obtained by the biowave
protocol at lower dilutions of antibody (Fig.5.1).
FIV and REV ELISA
Standardized antigen capture assays were available for detecting FIV and REV.
Therefore these assays were modified for detection with the BIOWAVE method. ELISA
was used to determine FIV and REV in cell culture supernatants using methods 1
through 4. For the FIV ELISA, with an increase in dilution of the cell culture
supernatant, a decrease in O.D. value was obtained for methods 1, 2 and 3. O.D. values
with method 3 were lower than those obtained with methods 1 and 2 (Fig. 5.2) and with
method 4, the O.D. values were very close to zero or negative (data not shown). The
undiluted cell culture supernatant gave a higher O.D. value with method 1 than method
2. Overall, O.D. values using method 1 were lower than those obtained using method 2.
O.D. values were obtained with undiluted cell culture supernatants up to a 1:64 dilution
of the cell culture supernatant for methods 1 and 2. Hence, both protocols were equally
sensitive to the same levels of virus (Fig. 5.2 and Fig. 5.3).
For the REV ELISA, the O.D. values increased with an increasing amount of gag
protein for all four methods used. The increase in O.D. values was comparable using
methods 1 and 2 up to 300 ng of protein; O.D. values for method 2 were slightly lower
than O.D. values for method 1. At 500 ng of protein, the O.D. value obtained with the
biowave using method 2 was considerably lower than that using method 1. Method 3
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FIG. 5.2. Comparison of the traditional and the biowave protocols for the detection of
FIV in cell culture supernatants using various dilutions of the supernatant. The standard
errors are less than 0.05.
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FIG. 5.3. Comparison of the traditional and the biowave protocols for the REV ELISA
using REV gag protein standards and antibody to the gag protein raised in rabbits. The
standard errors are less than 0.07.
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gave higher O.D.  values above 50 ng of protein as compared to methods 1 and 2.
Method 4 gave an increasing gradation of O.D. values with increasing protein amounts,
however the O.D. values were lower than the first three methods. 0.516, 0.377, 0.238
and 0.139 were the O.D. values of virus present in the supernatant obtained using
methods 1, 2, 3 and 4. Virus in the supernatant corresponded to approximately 235, 156,
80 and 235 ng of REV gag protein/ml as determined using methods 1, 2, 3 and 4
respectively.
Secondary antibody dilutions
The manufacturer recommended a 1:100 secondary antibody dilution. Very high
background O.D. values were obtained with the negative serum when a 1:100 dilution of
secondary antibody was used.  Hence, a 1:1000 dilution was used. The secondary
antibody dilutions for REV and FIV ELISAs were similar to that used for the
“traditional” ELISA protocols.
Substrates
For IBV ELISAs, BCIP-NBT was used as alkaline phosphatase substrate and
TMB was used as substrate for HRPO for REV and FIV ELISAs. The BIOWAVE works
well with both enzyme-substrate systems.
ELISA plates
The IBV ELISA works well only with the simulon flat bottom ELISA plates.
Very high backgrounds were obtained when high protein binding plates used for REV
and FIV detection was used for the IBV ELISA. On the other hand, the REV ELISA
worked well only with the high protein binding ELISA strips.
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DISCUSSION
Rapid detection of viruses and antibody to the virus is important in the diagnosis
of etiology of disease. ELISAs have been used for the detection of viruses and antibody
to the viruses. Traditional ELISAs for antigen or antibody detection take from 8 hours to
two days to obtain the results (Ndifuna et al., 1998). We have employed for the first
time, a special kind of a microwave called the BIOWAVE to decrease the processing
time to obtain the final result for antigen or antibody detection.
Here, we show that chicken serum antibody specific for IBV can be detected by a
modified ELISA in about an hour using the BIOWAVE as compared to almost 2 days by
the traditional protocol. The process time is considerably reduced greatly accelerating
the diagnosis. The biowave method is as sensitive as the traditional ELISA method for
detection of IBV antibody in chicken serum. Antibody can be detected up to 1:1000
dilutions by both methods. The O.D. values for the IBV ELISA follow the order, method
2 >  method 1 > method 3 > method 4. This suggested that the microwaves in the
BIOWAVE positively affect the IBV ELISA and that it is not a temperature-mediated
effect alone.
In order to determine the ability to use the BIOWAVE for detection of viral
antigens, the standardized ELISAs for the determination of FIV and REV in cell culture
supernatants were applied. O.D. values for the FIV ELISA follow the order, method 1 >
method 2 > method 3. Furthermore, both methods 1 and 2 for FIV detection were
comparable for sensitivity of virus determination. Hence in this case as well the
microwaves positively affect the ELISA. In the case of the REV ELISA O.D. values of
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protein standards follow the order, method 3 > method 1 > method 2 > method 4.
However, when the O.D. values of the virus in the supernatant are compared, they
follow the order method 1 > method 2 > method 3 > method 4.
How does microwave energy affect the interaction between proteins to expedite
the reaction? The exact mechanism of how microwaves cause heating is not known.
Microwaves affect hydrogen bonding of water and increase vibrational energy thereby
causing a quick transfer of energy between molecules. In the ELISAs that we have
tested, the BIOWAVE gives higher O.D. values as compared to the traditional methods
for the IBV and FIV ELISA’s. Microwaves probably alter the flexibility of the antibody
molecule as well as that of the antigen epitopes thereby enhancing the antigen-antibody
interaction. Microwaves also have an effect on the ability to solubilize the viral antigen
in presence of the detergent triton-X-100. With the FIV ELISA, the O.D. values for gag
detection using the BIOWAVE were closer to the O.D. values obtained using the
traditional method. Whereas, for the REV ELISA, the O.D. value for gag detection in the
virion using the biowave was lower than the value obtained using the traditional method
suggesting that the microwaves are likely to affect solubilization of the viral antigens. In
the case of the REV ELISA, the microwave energy did not solubilize the antigen as well
as what was obtained with the traditional protocol. Solubilization of viruses to release
the antigen is probably dependent on a combination of temperature and time.
The microwaves generated in the PELCO Biowave correspond to a frequency of
approximately 2.5 GHz. This  frequency corresponds to energy of 0.0002384 kcal/mol.
The resonance energy of a peptide bond for most amino acids is 20 kcal/mol, and except
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for proline it is 10 kcal/mole. It was proposed that the microwave energy might in some
way contribute to the resonance energy of the peptide bond, thereby leading to the
diffusion of energy between molecules. However, since the microwave energy is lower
than that of the peptide bond, this does not seem to be a possibility. There has to be some
other mechanism how microwave enhance the protein-protein interactions.
If the ELISA for virus detection is developed against a virus internal antigen, the
virus has to be solubilized using appropriate detergents to expose the internal antigen.
Both FIV and REV ELISAs were based on the detection of the gag antigen that is
internally present in the virion. Triton-X 100 at a final concentration of 20 % was used to
solubilize the virus. Detergent concentration is an important factor for disrupting viruses.
The type of plate used for the ELISA in general is important. For the IBV
antibody ELISA, we used the flat bottom simulon ELISA plates. For the REV and FIV
antigen ELISA, we used high protein binding strips. A very high background was
obtained when we used the high protein binding strips for the IBV-BIOWAVE ELISA.
The BIOWAVE microwave is a practical instrument to improve the processing
time of an ELISA. This could be applied to detect viral antigens or antibody to viruses.
A laboratory that uses the ELISA technique for the detection of any kind of antigen or
antibody to determine etiology of disease can benefit from the use of the BIOWAVE.
However, as with the traditional ELISAs, each antigen specific parameter needs to be
standardized.
131
CHAPTER VI
SUMMARY AND CONCLUSION
Coronavirus nucleocapsid (N) protein binds the viral genome forming a helical
nucleocapsid (Davies et al., 1981). IBV N protein is phosphorylated and it has been
speculated that phosphorylation contributes to the specificity of binding viral RNA.
Coronavirus N protein is multi-functional and it has been proposed that phosphorylation
might regulate the various roles of the N protein (Masters et al., 1990; Masters and
Sturman, 1990; Tahara et al., 1998) . We show here that the N protein is phosphorylated
at all times during IBV infection in the cell and from a maximum level of incorporation
there is only a 70% drop in the intensity of the labeled protein at the end of one hour.
MHV M has been shown to package nonviral RNA with the MHV packaging signal
sequence into virus-like particles. The MHV N protein is dispensable for this process
(Narayanan et al., 2003a; Narayanan and Makino, 2001). Hence, phosphorylation is
unlikely to contribute to specificity of RNA binding. It might however, increase the
affinity for viral RNA. Double labeling studies using 3H-leucine and 32P-orthophosphate
show that the N protein in the virion is more phosphorylated than the N protein from the
virus-infected cell isolated at various times during infection. This result also suggests
that enhanced phosphorylation of the N protein is important for some stage in virus
assembly. It is not yet known if the N protein is differentially phosphorylated. It is
possible that differential phosphorylation of the N protein is important in regulating
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transcription, translation, replication and packaging of the viral genome. It is of interest
to determine if various phosphorylated forms of the N protein exist in the cell.
Our results indicate that the bacterially expressed IBV N protein is not
phosphorylated (data not shown). Zhou et al. (1996) have shown that RNA binding by N
protein is not dependent on phosphorylation (Zhou et al., 1996). A large complex of the
recombinant N protein of molecular mass greater than 450 kilodalton (kDa) is obtained
by gel-permeation chromatography. Transmission electron microscopy (TEM) studies of
the recombinant N protein show that there are helical structures in the recombinant N
protein preparation.  These structures resemble nucleocapsid-like structures that are
found within the virion. The diameter of the nucleocapsid-like structures ranges from 6
to 10 nm and the lengths vary from 50 to 500 nm. The diameter of the nucleocapsids
obtained from the virion range from 10 to 14 nm and the lengths vary from 2 to 6 µm
(Davies et al., 1981). The variation in measurements of the virion nucleocapsid usually
depends on how compact the nucleocapsid is held. The measurements of the diameter
obtained for the IBV recombinant N protein nucleocapsid-like structures compare quite
closely to the original measurements. The variation in length may be attributed to N
binding to RNA of various lengths and specificity. These nucleocapsid-like structures
are not formed by truncations of the N protein that correspond to amino acids 1 to 91, 1
to 171, 203 to 409 and 268 to 407 of the N protein. Amino acids 1 to 171, 203 to 409
and 268 to 407 bind RNA (Zhou et al., 1996). Amino acids 268 to 407 of the carboxyl
region of the N protein form large aggregates that elute in the void volume when purified
by gel permeation chromatography through a Bio-gel P60 column, indicating that this
133
region interacts with itself. It is possible that N-N interaction and the RNA binding
domain are required for the formation of the nucleocapsid. We show here for the first
time that nucleocapsid-like structures are formed in the absence of other viral proteins.
Since the bacterially expressed protein is not phosphorylated, phosphorylation is not
necessary for the formation of nucleocapsid-like structures although it might be
important in specificity of RNA binding.
The significance of formation of nucleocapsid-like structures is relevant in
packaging the viral genome into the virion. Since other viral proteins are not required for
formation of these structures, it is possible that N protein binds RNA and forms these
structures. RNA is associated with the IBV recombinant N protein preparation. However
it is not known if RNA is present in these structures. Nucleocapsid proteins have a
tendency to oligomerize and self-assemble into such structures with the help of a RNA
backbone. Nucleocapsid proteins of negative strand RNA viruses such as vesicular
stomatitis virus (VSV), measles virus and rabies virus, form nucleocapsid-like structures
in the absence of other viral structural proteins. RNA is associated with these structures.
It is highly likely, therefore, that IBV N also forms these structures in the presence of an
RNA backbone with which the IBV N protein assembles. It is possible that certain
repeating oligomer units associate and form the helical nucleocapsid-like structure as has
been observed with the rabies and measles virus nucleocapsid protein (Fooks et al.,
1993; Iseni et al., 1998).
Since the coronavirus N protein binds subgenomic RNA and the viral genome
(Siddell et al., 1995), it is possible that certain other viral proteins may be required for
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specific binding and packaging of the viral genome. MHV M protein, when co-
expressed with the E protein, can package non-viral RNA that has the MHV packaging
signal sequence and form virus-like particles. The MHV N protein is indispensable for
this process (Narayanan et al., 2003a; Vennema et al., 1996). In the work reported by
Vennema et al (1996), the length of the RNA was only a thousand nucleotides long.
Where specificity of packaging likely depends on the interaction of other viral proteins
with a packaging signal sequence, packaging of the viral genome (26 to 31 kb) possibly
requires the N protein for compacting the genome. In the case of IBV, a putative
packaging signal sequence has been identified based on homology with the MHV and
BCV packaging signal sequences that are located in the 3’ end of ORF 1b (Cologna and
Hogue, 2000; Woo et al., 1997). In the case of TGEV, the packaging signal is located in
the 5’ end of the genome (Escors et al., 2003). However, is not known if the IBV
putative packaging signal sequence is functionally relevant.
Double labeling studies using 3H-leucine and 32P-orthophosphate have shown
that the 32P:3H cpm ratio is higher in the virion N than the 32P:3H cpm ratio in the N
protein from infected cell lysates, suggesting that the virion N protein is more
phosphorylated than the N protein from the infected cell lysates. The bacterially
expressed IBV recombinant N protein is not phosphorylated and can form nucleocapsid-
like structures in the absence of other viral proteins. So why is the N protein more
phosphorylated in the virion? It is possible that a) phosphorylation might regulate the
interaction of N protein with other viral proteins that are required for virus assembly, b)
phosphorylation of N causes better compaction of the viral genome that is packaged as a
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nucleocapsid into the virion, or c) phosphorylation increases the affinity of viral RNA
binding. Once the sites of phosphorylation on the N protein are identified, mutagenesis
of these sites can be performed to give a better idea of the role of phosphorylation of N
protein in the virus life cycle. Bordo and Argos (1991) have suggested replacement of
serine and threonine with alanine, and tyrosine with phenylalanine. These are considered
to be safe replacements because serine, threonine and alanine are closely related to each
other in structure and tyrosine and phenylalanine are closely related in structure (Bordo
and Argos, 1991). Both alanine and phenylalanine are not putative phosphorylation sites
and hence the effect of lack of phosphorylation of the protein can be studied by using
these amino acids for replacement.
IBV N protein binds certain viral sequences in the 3’-untranslated region with a
higher affinity (Zhou et al., 1996) than other viral sequences. Zhou has shown that RNA
binding to the 3’-UTR depends on the presence of U in the sequence. The 3’-UTR is
37% U-rich, which is higher than the rest of the genome. A sequence within the 3’-UTR
with a 45% U content was bound better than a sequence with a 6.5% U content (Zhou,
1997). We show here that IBV recombinant N protein binds U15-mer and U40-mer RNA.
Although binding to the U oligomer occurred in the presence of a large excess of yeast-t-
RNA as non-specific competitor, it is likely that binding of IBV N protein to RNA is
sequence and secondary structure dependent. It is possible that, since the 3’-UTR has a
higher U content (37%) than the rest of the genome, uridylates may contribute to N
binding to the 3’-UTR. The context of the U residues may also affect binding affinity of
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binding. It will be interesting to perform competitive gel-shift assays to determine the
relative binding of N to RNA U-oligomer and the sequence containing 45% U.
The presence of B cell epitopes on the IBV N protein and the conserved nature of
the protein, make it an important serodiagnostic reagent for IBV (Ndifuna et al., 1998;
Seah et al., 2000). IBV recombinant N protein expressed in bacteria has been previously
used as a serodiagnostic reagent to detect anti-IBV antibody in the serum of chickens
(Ndifuna et al., 1998). We employed the recombinant bacterially expressed histidine-
tagged N protein in the development of a rapid ELISA technique using a special
microwave called the BIOWAVE to detect anti-IBV antibody in serum of chickens. The
technique is superior to the regular ELISA as the time taken for the analysis with the
BIOWAVE is around one and a half hours in comparison to the protocol used for the
traditional ELISA. The BIOWAVE can be also used for the detection of other viruses as
we have shown for the detection of reticuloendotheliosis virus and feline
immunodeficiency virus in cell culture supernatants. The BIOWAVE can be used for
any ELISA once the process has been standardized.
FUTURE STUDIES
Objective 1. Determine the sites of phosphorylation on the cellular and virion N
protein.
Objective 2. Perform alanine/phenylalanine mutagenesis of the phosphorylated
sites on the N protein and determine the importance of phosphorylation in the virus life
cycle.
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Objective 3. Determine if RNA is present in the helical nucleocapsid-like
structures that are formed by the bacterially expressed IBV recombinant N protein using
RNase-A gold immunolabeling followed by transmission electron microscopy.
Objective 4. Determine using 2D crystallography if repeating oligomers of N-
protein are involved in forming the nucleocapsid-like structures.
Objective 5. Crystallize the IBV N protein.
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